RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Magnetic resonance imaging texture predicts progression to dementia due to Alzheimer disease earlier than hippocampal volume

J Psychiatry Neurosci 45(1):7-14 · 2020 · PMID 31228173

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

6,461편 검색→1,968편 판독→752편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: MRI predictors of Alzheimer disease progression (("Magnetic Resonance Imaging"[tiab] OR "MRI"[tiab] OR "magnetic resonance"[tiab] OR "MRI biomarker*"[tiab] OR "structural MRI"[tiab]) AND ("Alzheimer*"[tiab] OR "Alzheimer disease"[MeSH Terms] OR "Alzheimer's disease"[tiab] OR "mild cognitive impairment"[tiab]) AND ("predict*"[tiab] OR "predictor*"[tiab] OR "prognos*"[tiab] OR "progression"[tiab] OR "conversion"[tiab]))

출판 연도

2023: 1편120232024: 183편1832025: 297편2972026: 269편2692027: 2편22027

선별된 752편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01atrophy · volume176편

  1. 0.96

    A longitudinal analysis of T1-weighted MRI features associated with progression from mild cognitive impairment to Alzheimer's disease

    Wang Y, Song W, Yang X et al. · BMC medical imaging · 2026

  2. 0.95

    Longitudinal analysis of hippocampal subfield atrophy and network centrality associated with cognitive decline in Alzheimer's disease progression

    Lim S, Lee Y · Medical physics · 2026

  3. 0.94

    EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker

    Paranhos T, Katsumi Y, Brickhouse MJ et al. · Neurology · 2026

  4. 0.94

    Predicting progression from MCI to dementia using cortical disarray measurement from diffusion MRI

    Torso M, Khosropanah P, Chance SA et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  5. 0.94

    Atrophy of hippocampal subfields and amygdala nuclei in subjects with mild cognitive impairment progressing to Alzheimer's disease

    Punzi M, Sestieri C, Picerni E et al. · Heliyon · 2024

  6. 0.94

    Combined cognitive assessment and automated MRI volumetry improves the diagnostic accuracy of detecting MCI due to Alzheimer's disease

    Defrancesco M, Marksteiner J, Lenhart L et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2025

  7. 0.94

    Cortex-to-caudate volume ratio as a predictor of cognitive decline in Alzheimer's disease and mild cognitive impairment

    Na S, Kim T, Song IU et al. · Journal of the neurological sciences · 2024

  8. 0.93

    Differential MRI atrophy profiles and incident dementia: A cross-national comparison

    Walters ME, Small BJ, Andel R et al. · Journal of Alzheimer's disease : JAD · 2025

  9. 0.92

    Temporal atrophy together with verbal encoding impairment is highly predictive for cognitive decline in typical Alzheimer's dementia - a retrospective follow-up study

    Doganyigit B, Defrancesco M, Schurr T et al. · Frontiers in psychiatry · 2024

  10. 0.92

    Clinically feasible automated MRI volumetry of the brain as a prognostic marker in subjective and mild cognitive impairment

    Amland R, Selbaek G, Braekhus A et al. · Frontiers in neurology · 2024

  11. 0.92

    Baseline brain volumes predict cognitive decline more robustly than atrophy rates: Evidence for brain reserve

    Sambuco N, Scaramuzzi GF, Gasparre D et al. · Cortex; a journal devoted to the study of the nervous system and behavior · 2026

  12. 0.92

    Detecting limbic predominant neurodegenerative co-pathologies in vivo in Alzheimer's disease: magnetic resonance imaging markers, cognitive correlates, and prognosis

    Richter N, Onur OA, Fink GR · Alzheimer's research & therapy · 2025

  13. 0.92

    Longitudinal surface-based morphometry changes in the hippocampus in dementia

    Aziz S, Penheiro R, Morrison C et al. · Neuropsychologia · 2026

  14. 0.92

    Individualized cholinergic pathway degeneration in Alzheimer's disease characterized by normative modeling

    Feng S, Zhuang H, Xu C et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  15. 0.92

    Personalizing progressive changes to brain structure in Alzheimer's disease using normative modeling

    Verdi S, Rutherford S, Fraza C et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  16. 0.92

    Gray matter microstructure from in-vivo diffusion MRI reflects post-mortem neuropathology severity and clinical progression of Alzheimer's disease

    Alasmar Z, Tremblay C, Moqadam R et al. · medRxiv : the preprint server for health sciences · 2025

  17. 0.92

    Choroid plexus volumes and auditory verbal learning scores are associated with conversion from mild cognitive impairment to Alzheimer's disease

    Pearson MJ, Wagstaff R, Williams RJ · Brain and behavior · 2024

  18. 0.91

    Associations between ventricular boundary shift integral and composite cognitive domains across the alzheimer's disease continuum

    Nasiri H, Azimizonuzi H, Khosravi F et al. · Scientific reports · 2026

  19. 0.91

    White Matter Abnormalities and Cognition in Aging and Alzheimer Disease

    Peter C, Sathe A, Shashikumar N et al. · JAMA neurology · 2025

  20. 0.91

    "Back to Braak": Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression

    Censi S, Sestieri C, Punzi M et al. · The journal of prevention of Alzheimer's disease · 2024

  21. 0.91

    Atrophy of specific amygdala subregion precedes the conversion from mild cognitive impairment with neuropsychiatric symptoms to dementia

    Pan C, Ma J, Yuan X et al. · International psychogeriatrics · 2026

  22. 0.91

    Structural MRI and mild behavioral impairment as complementary predictors of conversion from amnestic MCI to Alzheimer's disease

    Tomyshev A, Cherkasov N, Panikratova Y et al. · Neuroscience · 2026

  23. 0.91

    Neuroanatomical and clinical factors predicting future cognitive impairment

    Imms P, Chaudhari NN, Chowdhury NF et al. · GeroScience · 2025

  24. 0.90

    Progression of hippocampal subfield atrophy and asymmetry in Alzheimer's disease

    Xu J, Tan S, Wen J et al. · The European journal of neuroscience · 2024

  25. 0.90

    High‑Resolution T2 MRI Volumetry of Medial Temporal Lobe Subregions Predicts Cognitive Decline Across the Alzheimer's Disease Continuum

    Mozafar M, Shahbazi S, Amirian MA et al. · Applied neuropsychology. Adult · 2025

  26. 0.90

    Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer's disease progression

    Shafiee N, Fonov V, Dadar M et al. · Neurobiology of aging · 2024

  27. 0.90

    MRI Distance Measures as a Predictor of Subsequent Clinical Status During the Preclinical Phase of Alzheimer's Disease and Related Disorders

    Zhang X, Caffo BS, Soldan A et al. · Human brain mapping · 2025

  28. 0.89

    Machine Learning-Based Perivascular Space Volumetry in Alzheimer Disease

    Deike K, Decker A, Scheyhing P et al. · Investigative radiology · 2024

  29. 0.89

    Gray matter microstructure from in vivo diffusion magnetic resonance imaging reflects post mortem neuropathology severity and clinical progression of Alzheimer's disease

    Alasmar Z, Tremblay C, Moqadam R et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  30. 0.89

    Free-water: A promising structural biomarker for cognitive decline in aging and mild cognitive impairment

    Sathe A, Yang Y, Schilling KG et al. · Imaging neuroscience (Cambridge, Mass.) · 2024

  31. 0.89

    Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization

    Shui L, Shibata D, Chan KCG et al. · Journal of Alzheimer's disease : JAD · 2024

  32. 0.89

    Baseline and longitudinal changes in cortical thickness and hippocampal volume predict cognitive decline

    Chen G, McKay NS, Gordon BA et al. · Journal of Alzheimer's disease : JAD · 2025

  33. 0.89

    Subcortical gray matter volumes and 5-year dementia risk in individuals with subjective cognitive decline or mild cognitive impairment: A multi-cohort analysis

    Rosbergen MT, van der Veere P, Claus JJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  34. 0.89

    Impact of the Ventricle Size on Alzheimer's Disease Progression: A Retrospective Longitudinal Study

    Lee JS, Heo DY, Choi KH et al. · Dementia and neurocognitive disorders · 2024

  35. 0.89

    Mechanomarker-informed identification of Alzheimer's disease based on lateral ventricular deformation

    Cunniff L, Weickenmeier J · Brain research bulletin · 2026

  36. 0.89

    Definition and analysis of gray matter atrophy subtypes in mild cognitive impairment based on data-driven methods

    Zhang B, Xu M, Wu Q et al. · Frontiers in aging neuroscience · 2024

  37. 0.88

    Decoupling of Neurochemical and White Matter Microstructural Integrity in Posterior Cingulate Cortex Predicts Early Alzheimer's Disease Progression

    Sun YW, Lei XY, Lyu XY et al. · Neurochemical research · 2025

  38. 0.88

    Heterogeneous progression of AT(N) biomarkers in data-driven subtypes of Alzheimer's disease

    Teng Z, Hu M, Zhang Z et al. · Frontiers in aging neuroscience · 2026

  39. 0.88

    SMAS: Structural MRI-based AD Score using Bayesian supervised VAE

    Nemali A, Bernal J, Yakupov R et al. · Computers in biology and medicine · 2025

  40. 0.88

    Enhanced monitoring of Alzheimer's disease brain atrophy using composite value ratios of volumes

    Llorente-Saguer I, Oxtoby NP · Brain communications · 2026

  41. 0.88

    Brain age as an accurate biomarker of preclinical cognitive decline: evidence from a 12-year longitudinal study

    Elkana O, Beheshti I · Journal of neurology · 2025

  42. 0.88

    Disrupted single-subject gray matter networks are associated with cognitive decline and cortical atrophy in Alzheimer's disease

    Xiao Y, Gao L, Hu Y · Frontiers in neuroscience · 2024

  43. 0.88

    Sex-dependent grey matter atrophy in Alzheimer's disease progression

    Mukherjee C, Bajaj S, Adhikari BM et al. · Brain communications · 2026

  44. 0.88

    Predicting risk of impending cognitive decline in asymptomatic individuals with early Alzheimer's disease: Insights from cortical diffusion MRI

    Overson DK, Truong TK, Petrella JR et al. · Imaging neuroscience (Cambridge, Mass.) · 2025

  45. 0.87

    Repeated brain MRI utility in identifying neurodegenerative disorders at the pre-dementia stage

    Carbone C, Gallingani C, Balboni E et al. · Neurobiology of aging · 2025

  46. 0.87

    Associations between temporal lobe cortical NODDI measures and memory function in individuals without clinical dementia

    Pillai JJ, Reid RI, Weigand SD et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  47. 0.87

    A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings

    Baumeister H, Vogel JW, Insel PS et al. · Brain : a journal of neurology · 2024

  48. 0.87

    MRI-Driven Longitudinal Studies of Hippocampal Alterations During the Initial Cognitive Decline

    Dong Q, Sheng Y, Zhu J et al. · IEEE journal of translational engineering in health and medicine · 2025

  49. 0.87

    Baseline Brain Volumes Predict Future Brain Atrophy in Mild Cognitive Impairment: A Tensor-based Morphometry Study of the Alzheimer Continuum

    Mozafar M, Amanollahi M, Sadeghi M et al. · Journal of computer assisted tomography · 2025

  50. 0.86

    Circulating Homocysteine and Choroid Plexus Volume Across the Alzheimer's Disease Continuum: Cross-Sectional and Progression-Related Associations

    Feng C, Zhang T, Liu X et al. · Biology · 2026

  51. 0.86

    Validation of a novel neuroimaging signature for dementia and clinical Alzheimer's disease in the population-based Rotterdam study

    Claus JJ, Rosbergen MT, Roshchupkin GV et al. · Journal of Alzheimer's disease : JAD · 2025

  52. 0.85

    Trajectory of olfactory cortex degeneration from normal cognition to Alzheimer's disease: Insights from multimodal neuroimaging

    Yang S, Xie B, Liao D et al. · Neurobiology of disease · 2025

  53. 0.85

    Atrophy trajectories in Alzheimer's disease: how sex matters

    Inguanzo A, Poulakis K, Oltra J et al. · Alzheimer's research & therapy · 2025

  54. 0.85

    Disease stage-specific atrophy markers in Alzheimer's disease

    Baumeister H, Gellersen HM, Polk SE et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  55. 0.85

    Cortical thickness subtypes in cognitively unimpaired individuals: Differential network and transcriptomic vulnerability to cortical thinning

    Lorenzini L, Tranfa M, Pieperhoff L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  56. 0.85

    Sex-specific effects of apolipoprotein E epsilon4 genotype on longitudinal hippocampal atrophy in amnestic mild cognitive impairment over a 2-year evaluation period

    Park CH, Lee H, Lee YM et al. · Journal of Alzheimer's disease : JAD · 2025

  57. 0.85

    Predicting longitudinal basal forebrain volume in the Alzheimer's disease spectrum: the role of sex and ApoE epsilon 4 genotype

    Grazia A, Levin F, Jessen F et al. · Frontiers in neuroscience · 2026

  58. 0.84

    The degeneration of locus coeruleus occurring during Alzheimer's disease clinical progression: a neuroimaging follow-up investigation

    Galgani A, Lombardo F, Frijia F et al. · Brain structure & function · 2024

  59. 0.84

    Late-life body mass index and Alzheimer disease conversion in mild cognitive impairment: Nonlinear risk and structural MRI correlates

    Xu X, Yu J, Zhao R et al. · Archives of gerontology and geriatrics · 2026

  60. 0.83

    Cortical tortuosity as a potential clinical biomarker for Alzheimer's disease: A 3D MRI analysis of brain morphological changes

    Mateos MJ, Lah JJ, Qiu D · NeuroImage. Clinical · 2025

  61. 0.83

    Connectivity related to major brain functions in Alzheimer disease progression: microstructural properties of the cingulum bundle and its subdivision using diffusion-weighted MRI

    Ricchi M, Campani G, Nagmutdinova A et al. · European radiology experimental · 2025

  62. 0.83

    Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline

    Guan DX, Rehman T, Nathan S et al. · Human brain mapping · 2024

  63. 0.82

    The associations between cerebral microhemorrhages and cognitive decline across Alzheimer's continuum

    Khaledian H, Rad AJ, Barjisi P et al. · Aging clinical and experimental research · 2025

  64. 0.81

    Amygdala subregional atrophy across ATN-defined Mild Cognitive Impairment subgroups

    Yuan Q, Xue C, Qi W et al. · Frontiers in neuroscience · 2026

  65. 0.81

    Local gyrification index and sulcal depth as imaging markers of cognitive decline in Alzheimer's disease

    Sim Y, Seo C, Lee YG et al. · Frontiers in aging neuroscience · 2025

  66. 0.80

    Brain Iron in signature regions relating to cognitive aging in older adults: the Taizhou Imaging Study

    Li R, Fan YR, Wang YZ et al. · Alzheimer's research & therapy · 2024

  67. 0.80

    Specific atrophy patterns distinguish tau and TDP-43 pathology: a longitudinal MRI ante-mortem study

    Salman Y, Goloubeva J, Huyghe L et al. · Acta neuropathologica communications · 2025

  68. 0.80

    Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up

    Lee AJ, Stark JH, Hayes SM · Journal of Alzheimer's disease : JAD · 2024

  69. 0.80

    Differential atrophy along the longitudinal hippocampal axis in Alzheimer's disease

    Morais-Ribeiro R, Almeida FC, Coelho A et al. · The European journal of neuroscience · 2024

  70. 0.79

    Structural white matter connectivity differences independent of gray matter loss in mild cognitive impairment with neuropsychiatric symptoms: Early indicators of Alzheimer's disease using network-based statistics

    Pajavand AM, Grothe MJ, De Schotten MT et al. · Journal of Alzheimer's disease : JAD · 2024

  71. 0.79

    Structural MRI Biomarkers Related to Cognitive Recovery and Resistance to Recovery Using the Penalized Mixture Cure Model

    Pahlevani V, Eskanadri F, Almasi-Dooghaee M et al. · Basic and clinical neuroscience · 2025

  72. 0.79

    Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease

    Ferraro PM, Filippi L, Ponzano M et al. · Journal of Alzheimer's disease : JAD · 2025

  73. 0.79

    Hyperintensity of the left piriform cortex and amygdala on T2-weighted FLAIR images in patients with probable Alzheimer's disease correlates with cerebral cortical atrophy

    Ishizaka H, Sekine A, Naka M et al. · Acta radiologica open · 2025

  74. 0.79

    Early Cortical Microstructural Changes in Aging Are Linked to Vulnerability to Alzheimer's Disease Pathology

    Tang R, Franz CE, Hauger RL et al. · Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024

  75. 0.78

    Single-value brain activity scores reflect both severity and risk across the Alzheimer's continuum

    Soch J, Richter A, Kizilirmak JM et al. · Brain : a journal of neurology · 2024

  76. 0.78

    Atrophy patterns of deep gray matter nuclei in Alzheimer's disease and frontotemporal dementia

    Banerjee A, Yang F, Dutta J et al. · Journal of Alzheimer's disease : JAD · 2025

  77. 0.78

    Biological plausibility of single-shell NODDI-DTI in non-demented older adults: associations with plasma biomarkers and follow-up cognition

    Restuccia G, Ielo A, Buono VL et al. · Research square · 2026

  78. 0.78

    Alterations in hippocampus-centered morphological features and function of the progression from normal cognition to mild cognitive impairment

    Wang X, Peng L, Zhan S et al. · Asian journal of psychiatry · 2024

  79. 0.78

    Multimodal DTI-ALPS and hippocampal microstructural signatures unveil stage-specific pathways in Alzheimer's disease progression

    Yu P, Shen L, Tang L · Frontiers in aging neuroscience · 2025

  80. 0.78

    Amygdala atrophies in specific subnuclei in preclinical Alzheimer's disease

    Salman Y, Gerard T, Huyghe L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  81. 0.77

    Neuropsychological and neuroimaging characteristics of patients with mild cognitive impairment and negative-amyloid deposition

    Dai X, Zhang J, Li X et al. · Frontiers in neurology · 2025

  82. 0.77

    Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuum

    Buehner BJ, Morcillo-Nieto AO, Zsadanyi SE et al. · Brain : a journal of neurology · 2025

  83. 0.77

    Cognitive heterogeneity in mild cognitive impairment due to Alzheimer's disease pathology

    Chen S, Salmon DP, Feldman HH et al. · Neural regeneration research · 2026

  84. 0.77

    Seeing beyond the symptoms: biomarkers and brain regions linked to cognitive decline in Alzheimer's disease

    Hojjati SH, Babajani-Feremi A · Frontiers in aging neuroscience · 2024

  85. 0.77

    Age-Related Differences in the Choroid Plexus Structural Integrity Are Associated with Changes in Cognition

    Gong Z, de Rouen A, Zhang N et al. · medRxiv : the preprint server for health sciences · 2025

  86. 0.75

    Activities of daily living and their neural correlates across the Alzheimer's disease continuum: Evidence from a Latin American cohort

    Henriquez F, Riquelme P, Forno G et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  87. 0.75

    Exploration of neuroanatomical characteristics to differentiate prodromal Alzheimer's disease from cognitively unimpaired amyloid-positive individuals RECODE

    Kim HH, Kwon MJ, Jo S et al. · Scientific reports · 2024

  88. 0.75

    Exploring morphological and microstructural signatures across the Alzheimer's spectrum and risk factors

    Bussy A, Patel R, Parent O et al. · Neurobiology of aging · 2025

  89. 0.75

    Mapping Divergent Subfield-Specific Hippocampal Degeneration in Mild Cognitive Impairment Continuum: Volumetric, Cognitive, and Genetic Predictors of Accelerated Hippocampal Biological Aging

    Ghaderi S, Mohammadi S, Fatehi F · CNS neuroscience & therapeutics · 2025

  90. 0.74

    Distinct spatiotemporal patterns of cortical thinning in Alzheimer's disease-type cognitive impairment and subcortical vascular cognitive impairment

    Kim J, Kim J, Park YH et al. · Communications biology · 2024

  91. 0.74

    Psychosis in Alzheimer's disease is associated with specific changes in brain MRI volume, cognition and neuropathology

    Almeida FC, Jesus T, Coelho A et al. · Neurobiology of aging · 2024

  92. 0.74

    Investigating the Correlation Between Gray Matter Volume Changes and Cognitive Function Among Alzheimer's Disease Patients: An MRI-Based Analysis

    Sun Q, Ma L, Zhao L et al. · Actas espanolas de psiquiatria · 2025

  93. 0.74

    Vulnerability to memory decline in aging - a mega-analysis of structural brain change

    Vidal-Pineiro D, Sorensen O, Stromstrad M et al. · bioRxiv : the preprint server for biology · 2025

  94. 0.73

    Lewy body co-pathology in Alzheimer's disease and primary age-related tauopathy contributes to differential neuropathological, cognitive, and brain atrophy patterns

    Almeida FC, Santos A, Jesus T et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  95. 0.72

    A DERIVED RELAXATION CONTRAST FROM SYNTHETIC MRI FOR DETECTING NETWORK MICROSTRUCTURAL VULNERABILITY

    Ekanayake A, Hwang S, Peiris S et al. · bioRxiv : the preprint server for biology · 2026

  96. 0.72

    Atrophy of the cholinergic regions advances from early to late mild cognitive impairment

    Lai YLL, Hsu FT, Yeh SY et al. · Neuroradiology · 2024

  97. 0.72

    Achieving detailed medial temporal lobe segmentation with upsampled isotropic training from implicit neural representation

    Li Y, Khandelwal P, Jena R et al. · NeuroImage · 2026

  98. 0.72

    APOE epsilon4 allele status modulates the spatial patterns of progressive atrophy in the temporal lobes after mild traumatic brain injury

    Gan S, Sun Y, Liu K et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  99. 0.71

    Hippocampal subfields: volume, neuropathological vulnerability and cognitive decline in Alzheimer's and Parkinson's disease

    Bouwman MMA, Frigerio I, Lin CP et al. · Alzheimer's research & therapy · 2025

  100. 0.71

    Sex and APOE genotype specific brain regional vulnerability to Alzheimer's Disease

    Zeng Q, Wang M, Wang E et al. · GeroScience · 2026

  101. 0.70

    A Case Series on Longitudinal Hypothalamic Morphology in Mild Cognitive Impairment

    Pagaduan JC, Marzan MB, Wang X et al. · Annals of geriatric medicine and research · 2026

  102. 0.70

    Patterns of cortical thickness in MCI patients with and without semantic impairment

    Delage E, Rouleau I, Akzam-Ouellette MA et al. · Brain and cognition · 2025

  103. 0.70

    Vulnerability to memory decline in aging revealed by a mega-analysis of structural brain change

    Vidal-Pineiro D, Sorensen O, Stromstad M et al. · Nature communications · 2025

  104. 0.69

    Diffusion kurtosis imaging detects cortical microstructural alterations in amyloid-positive MCI patients

    Nielsen RB, Parbo P, Ismail R et al. · Frontiers in dementia · 2025

  105. 0.69

    Mapping the impact of age and APOE risk factors for late onset Alzheimer's disease on long range brain connections through multiscale bundle analysis

    Stout J, Anderson RJ, Mahzarnia A et al. · Brain structure & function · 2025

  106. 0.69

    Generalizable MRI normative modelling to detect age-inappropriate neurodegeneration

    Parker TD, Bethlehem RAI, Seidlitz J et al. · Alzheimer's research & therapy · 2025

  107. 0.69

    Abnormal Gyrus Rectus Asymmetry in Alzheimer's Disease: An MRI-Based Parcellation Method

    Karaca O, Kibar AA, Aslantekin B et al. · Brain sciences · 2025

  108. 0.68

    Association of CSF neurogenin-1 levels with cognitive decline and structural MRI features in older adults

    Chen S, Ye X, Wang Q · Scientific reports · 2025

  109. 0.68

    Distinguishing Early from Late Mild Cognitive Impairment Using Magnetic Resonance Free-Water Diffusion Tensor Imaging

    Bergamino M, McElvogue MM, Stokes AM et al. · NeuroSci · 2025

  110. 0.68

    Multimodal neuroimaging approach for cognitive impairment in Alzheimer's disease

    Gonzales M, Kang X, Adamson MM et al. · medRxiv : the preprint server for health sciences · 2026

  111. 0.68

    Neurite Degradation Mediates the Effect of Amyloid Deposition on Global Cognition in Asymptomatic Older Adults

    Hakhu S, Schaefer SY, Beeman SC · medRxiv : the preprint server for health sciences · 2025

  112. 0.67

    Age-related differences in choroid plexus structural integrity are associated with changes in cognition

    Gong Z, de Rouen A, Zhang N et al. · Fluids and barriers of the CNS · 2025

  113. 0.67

    Mapping the impact of age and APOE risk factors for late onset Alzheimer's disease on long range brain connections through multiscale bundle analysis

    Stout J, Anderson RJ, Mahzarnia A et al. · bioRxiv : the preprint server for biology · 2024

  114. 0.67

    Neuroanatomical aging diversity of Alzheimer's disease revealed by BrainAGE

    He L, Sun G, Zhang G et al. · CNS spectrums · 2025

  115. 0.67

    The effects of traumatic brain Injury, post-traumatic stress disorder on Amyloid-beta associated network hyperconnectivity and progression of gray matter atrophy

    Mueller SG · NeuroImage. Clinical · 2025

  116. 0.67

    Stage-Dependent beta-Synuclein Links MRI and Cognitive Decline in Alzheimer's Disease

    Ay U, Alaylioglu M, Sahin E et al. · Annals of clinical and translational neurology · 2026

  117. 0.67

    Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases

    Ye R, Goodheart AE, Locascio JJ et al. · Neurology · 2024

  118. 0.67

    Associations between structural neuroimaging markers and neuropathology of Alzheimer's Disease

    Frenzel S, Teipel SJ, Grabe HJ · NeuroImage · 2026

  119. 0.66

    Serum Lipoprotein Subclasses as Predictors of Tensor-Based Morphometry Atrophy in the Alzheimer Disease Continuum: A Brief Report

    Khosravi F, Ashrafi M, Abroushan D et al. · Alzheimer disease and associated disorders · 2026

  120. 0.66

    Serum Klotho Levels, Brain Structure, and Cognitive Performance

    Czaplicki AM, Frahmand Driscoll I, Ma Y et al. · JAMA neurology · 2026

  121. 0.66

    Using diffusion MRI to relate hippocampal subfield microstructure to delayed verbal memory in cognitively intact individuals at genetic risk for developing Alzheimer's disease

    VanGilder JL, Hooyman A, Hakhu S et al. · Experimental gerontology · 2026

  122. 0.65

    Greater baseline cortical atrophy in the dorsal attention network predicts faster clinical decline in Posterior Cortical Atrophy

    Katsumi Y, Eckbo R, Chapleau M et al. · Alzheimer's research & therapy · 2024

  123. 0.65

    Effect of dorsolateral prefrontal cortex structural measures on neuroplasticity and response to paired-associative stimulation in Alzheimer's dementia

    Naveed K, Rashidi-Ranjbar N, Kumar S et al. · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024

  124. 0.65

    A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer's disease

    Venkatraghavan V, Archetti D, Bourgeat P et al. · NeuroImage · 2025

  125. 0.64

    Multi-shell diffusion MRI of the fornix as a biomarker for cognition in Alzheimer's disease

    Sakaie K, Koenig K, Lerner A et al. · Magnetic resonance imaging · 2024

  126. 0.64

    NODDI-derived measures of microstructural integrity in medial temporal lobe white matter pathways are associated with Alzheimer's disease pathology and cognition

    Parker DM, Adams JN, Kim S et al. · Imaging neuroscience (Cambridge, Mass.) · 2025

  127. 0.64

    The impact of polygenic risk for alzheimer's disease on neurotransmitter-related grey matter atrophy in the alzheimer continuum

    Manca R, Mitolo M, Bacalini MG et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025

  128. 0.64

    Distinct Patterns of Cortical Atrophy Predict Cognitive Progression in Age-Related Hearing Loss: A Longitudinal MRI Study

    Hong L, Zeng Q, Luo X et al. · AJNR. American journal of neuroradiology · 2026

  129. 0.64

    Focal hippocampal subfield atrophy in cognitively impaired relative to cognitively unimpaired older adults is associated with memory ability

    Heller-Wight A, Ellis DG, Wilhelm A et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  130. 0.64

    Stage-dependent effects of cognitive reserve on memory and brain structural integrity across the spectrum from healthy aging to Alzheimer's disease

    Serra L, Bonarota S, Caruso G et al. · Frontiers in human neuroscience · 2026

  131. 0.63

    Right-lateralized cerebellar cortical thickening is associated with mild behavioral impairment in mild cognitive impairment

    Kim S, Jung YC, Kim E et al. · The journal of prevention of Alzheimer's disease · 2026

  132. 0.63

    Longitudinal trajectories of cognitive decline and temporal lobe atrophy based on baseline gonadotropins and testosterone

    Zhao M, Jiang J, Wang L et al. · Frontiers in neuroscience · 2025

  133. 0.63

    Amygdala microstructural changes in subjective cognitive decline: A diffusion kurtosis and neurite orientation dispersion and density imaging study

    Flaherty R, Sui YV, Masurkar AV et al. · Journal of Alzheimer's disease : JAD · 2026

  134. 0.63

    An exploratory synthetic MRI-derived FLAIR-DIR contrast in olfactory-limbic regions in mild cognitive impairment

    Ekanayake A, Hwang S, Peiris S et al. · Journal of Alzheimer's disease : JAD · 2026

  135. 0.63

    Associations Between Cortical Iron Accumulation and Memory in Patients With Amnestic Mild Cognitive Impairment and in Cognitively Normal Individuals

    Lee S, Lee S, Park I et al. · Brain and behavior · 2025

  136. 0.62

    Different aspects of failing to recover from proactive semantic interference predicts rate of progression from amnestic mild cognitive impairment to dementia

    Curiel Cid RE, Crocco EA, Duara R et al. · Frontiers in aging neuroscience · 2024

  137. 0.62

    Evaluation of the association between MREPT-derived conductivity and IVIM-derived ISF-related metrics in the brains of patients with cognitive impairments

    Jung J, Katoch N, Rhee HY et al. · Frontiers in aging neuroscience · 2026

  138. 0.61

    Alterations in driving ability and their relationship with morphometric magnetic resonance imaging indicators in patients with amnestic mild cognitive impairment and Alzheimer's disease

    Wakita H, Takahashi Y, Masuzugawa S et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2024

  139. 0.60

    Regional tau PET patterns predict prospective domain-specific cognitive decline in early symptomatic Alzheimer's disease

    Malpetti M, Rathore S, Iaccarino L et al. · Alzheimer's research & therapy · 2025

  140. 0.60

    The Cortical Asymmetry Index for subtyping dementia patients

    Perez-Millan A, Lal-Trehan Estrada UM, Falgas N et al. · European radiology · 2025

  141. 0.60

    Association of Alzheimer's and Lewy body disease pathology with basal forebrain volume and cognitive impairment

    Schumacher J, Teipel S, Storch A · Alzheimer's research & therapy · 2025

  142. 0.60

    Age-disproportionate atrophy in Alzheimer's disease and Parkinson's disease spectra

    Yoshinaga K, Matsushima T, Abe M et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2025

  143. 0.59

    The spectrum of Alzheimer's disease

    Novotny JS, Carna M, Lyburn I et al. · medRxiv : the preprint server for health sciences · 2025

  144. 0.59

    The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE epsilon4 non-carriers with mild cognitive impairment due to Alzheimer's disease

    Bakker A, Rani N, Mohs R et al. · Alzheimer's & dementia (New York, N. Y.) · 2024

  145. 0.59

    Sex differences in white matter amplitude of low-frequency fluctuation associated with cognitive performance across the Alzheimer's disease continuum

    Chen X, Zhou S, Wang W et al. · Journal of Alzheimer's disease : JAD · 2025

  146. 0.59

    Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease

    Lin M, Chiotis K, Maiti P et al. · Brain communications · 2026

  147. 0.59

    VR-based path integration predicts individual risk of rapid cortical decline: a one-year longitudinal study in cognitively unimpaired adults

    Kawabata K, Shima S, Ohdake R et al. · Alzheimer's research & therapy · 2026

  148. 0.58

    Biological classification of memory clinic patients

    Mastenbroek SE, Collij LE, Anijarv TE et al. · Brain : a journal of neurology · 2026

  149. 0.58

    Cortical thickness and grey-matter volume anomaly detection in individual MRI scans: Comparison of two methods

    Romascano D, Rebsamen M, Radojewski P et al. · NeuroImage. Clinical · 2024

  150. 0.58

    Prediction of brain age using structural magnetic resonance imaging: a comparison of clinical utility of publicly available software packages

    Dorfel RP, Ozenne B, Ganz M et al. · EBioMedicine · 2026

  151. 0.58

    Dynamic long-term modulation of cognition, brain structure and covariance networks in mild cognitive impairment due to AD by donepezil: A 36-month longitudinal study

    Chen Y, Tong Z, Wang H et al. · Journal of neurology · 2026

  152. 0.57

    Diagnosing preclinical and clinical Alzheimer's disease with visual atrophy scales in the clinical practice

    Socher KLR, Nunes DM, Lopes DCP et al. · Arquivos de neuro-psiquiatria · 2025

  153. 0.57

    Clinical study on gray matter volume reduction, gait disorders, and fall risk in patients with Alzheimer's disease

    Wang S, Yang Y, Cheng K et al. · Frontiers in neurology · 2026

  154. 0.57

    Sodium signal intensity of CSF using 1H-guided 23Na-MRI as a potential noninvasive biomarker in Alzheimer's disease

    Kerl HU, Baazaoui H, Herrmann K et al. · Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2024

  155. 0.55

    Neuroanatomical-based machine learning prediction of Alzheimer's Disease across sex and age

    Jogeshwar BK, Lu S, Nephew BC · Neuroscience · 2026

  156. 0.55

    Detection of Alzheimer's Disease Using Hybrid Meta-ROI of MRI Structural Images

    Zheng X, On Behalf Of The Alzheimer's Disease Neuroimaging Initiative · Diagnostics (Basel, Switzerland) · 2024

  157. 0.55

    Memory impairment in Amyloidbeta-status Alzheimer's disease is associated with a reduction in CA1 and dentate gyrus volume: In vivo MRI at 7T

    Hari I, Adeyemi OF, Gowland P et al. · NeuroImage · 2024

  158. 0.54

    Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohorts

    Katsumi Y, Touroutoglou A, Brickhouse M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  159. 0.54

    Amino acid patterns predict white matter integrity measures in the brain in patients across the Alzheimer's disease continuum

    Goharmanesh F, Masmoie M, Nasiri H et al. · Metabolic brain disease · 2025

  160. 0.54

    Association of cumulative deficit frailty with brain age and Alzheimer's disease-related brain structure starting in late-middle age

    Hunt JFV, Buchholz EJ, Franz CE et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026

  161. 0.54

    Explainable AI-based Deep-SHAP for mapping the multivariate relationships between regional neuroimaging biomarkers and cognition

    Bhattarai P, Thakuri DS, Nie Y et al. · European journal of radiology · 2024

  162. 0.54

    Neuropsychiatric Symptom Clusters and Their Association With Brain Structure in Alzheimer Disease

    Kapustin D, Rashidi-Ranjbar N, Wang W et al. · The Journal of clinical psychiatry · 2026

  163. 0.53

    An effective and robust lattice Boltzmann model guided by atlas for hippocampal subregions segmentation

    Liu Y, Wang M, Yu X et al. · Medical physics · 2024

  164. 0.53

    Differences in cerebral structure among patients with amnestic mild cognitive impairment and patients with Alzheimer's disease

    Cui X, Li M, Lei G et al. · Frontiers in aging neuroscience · 2024

  165. 0.53

    Prediction of brain age using structural magnetic resonance imaging: A comparison of clinical validity of publicly available software packages

    Dorfel RP, Ozenne B, Ganz M et al. · medRxiv : the preprint server for health sciences · 2025

  166. 0.52

    Evaluation of Mild Cognitive Impairment through Perientorhinal/Hippocampal Imaging and Comprehensive Neuropsychological and Psychophysical Assessment

    Invitto S, Boscolo-Rizzo P, Spinato G et al. · Brain sciences · 2024

  167. 0.52

    Association of plasma BMP6 levels with the rates of brain atrophy in older people without dementia

    Zhang X, Fu P, Cai Y · Frontiers in neurology · 2025

  168. 0.52

    Erythrocyte Load in Cerebrospinal Fluid Linked with Hippocampal Atrophy in Alzheimer's Disease

    Christodoulou R, Vamvouras G, Lorentzen L et al. · Journal of clinical medicine · 2025

  169. 0.51

    Brain Iron as a Surrogate Biomarker of Pathological TDP-43 Identifies Brain Region-Specific Signatures in Ageing, Alzheimer's Disease and Amyotrophic Lateral Sclerosis

    Waldron FM, Spence H, Taso OS et al. · bioRxiv : the preprint server for biology · 2025

  170. 0.51

    Data-driven subtypes of subjective cognitive decline: neuropsychological profiles, Alzheimer's disease biomarkers, and clinical trajectories

    Mazzeo S, Boveri S, Bortolin E et al. · Journal of neurology · 2025

  171. 0.51

    Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease

    Memon A, Moore JA, Kang C et al. · Journal of Alzheimer's disease : JAD · 2024

  172. 0.51

    Neurometabolic topography and associations with cognition in Alzheimer's disease: A whole-brain high-resolution 3D MRSI study

    Hu J, Zhang M, Zhang Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  173. 0.51

    Differences in cognitive performance and neuroanatomy according to Alzheimer's disease pathophysiology

    Ribeiro IC, Goncalves BC, Aventurato IK et al. · Arquivos de neuro-psiquiatria · 2026

  174. 0.50

    Correlating hippocampal and amygdala volumes with neuropathological burden in neurodegenerative diseases using 7T postmortem MRI

    Liou JJ, Li J, Berardinelli J et al. · medRxiv : the preprint server for health sciences · 2024

  175. 0.50

    Daily function outcomes in adults with mild cognitive impairment due to Alzheimer's disease after two years of processing speed training versus a control training protocol

    Wadley VG, Zhang Y, Bull T et al. · Journal of Alzheimer's disease : JAD · 2025

  176. 0.50

    Development of Efficient Brain Age Estimation Method Based on Regional Brain Volume From Structural Magnetic Resonance Imaging

    Kim S, Wang SM, Kang DW et al. · Psychiatry investigation · 2024

02tau · amyloid145편

  1. 0.93

    Early axonal degeneration linked to clinical decline in Alzheimer's disease progression revealed with diffusion MRI

    Gong Z, Laporte JP, Guo AY et al. · The Journal of clinical investigation · 2026

  2. 0.93

    Hippocampal asymmetry captures non-amyloid-related risk of memory decline and clinical progression

    Ghanbarian E, Khorsand B, Zheng L et al. · The journal of prevention of Alzheimer's disease · 2026

  3. 0.92

    Axonal Degeneration Across the Alzheimer's Disease Spectrum: A Longitudinal MRI and Fluid Biomarker Study

    Gong Z, Laporte JP, Guo AY et al. · medRxiv : the preprint server for health sciences · 2025

  4. 0.92

    Lower Locus Coeruleus Integrity Signals Elevated Entorhinal Tau and Clinical Progression in Asymptomatic Older Individuals

    Engels-Dominguez N, Riphagen JM, Van Egroo M et al. · Annals of neurology · 2024

  5. 0.92

    Susceptibility MRI Helps Predict Mild Cognitive Impairment Onset and Cognitive Decline in Cognitively Unimpaired Older Adults

    Chen L, Soldan A, Faria A et al. · Radiology · 2025

  6. 0.91

    Catecholaminergic nucleus integrity and Alzheimer's pathology, symptoms, and progression

    David MCB, Kolanko MA, Parker TD et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  7. 0.91

    Neuroimaging Epicenters as Vulnerable Nodes in Plasma p-tau217/Abeta42-Positive Alzheimer's Disease

    Li Q, Liu Y, Chen Q et al. · Research (Washington, D.C.) · 2026

  8. 0.91

    Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease

    Yoo HS, Kim HK, Lee JH et al. · Journal of Alzheimer's disease : JAD · 2024

  9. 0.91

    Association Between Choroid Plexus Morphological Alterations, Alzheimer Pathologies, and Cognitive Impairment: A Longitudinal Study

    Lin M, Zeng Q, Zhong S et al. · Neurology · 2025

  10. 0.90

    Independent and interactive contributions of white matter hyperintensities and Alzheimer's disease imaging and plasma biomarkers to cognitive decline in older adults without dementia

    Bachmann D, Gericke C, Wybitul M et al. · Alzheimer's research & therapy · 2026

  11. 0.89

    Surrogates of glymphatic metrics decline and coupled sleep rhythms disruption in Alzheimer's disease

    Liu X, Wei T, Zhao B et al. · Alzheimer's research & therapy · 2026

  12. 0.89

    Cortical asymmetry in autosomal dominant Alzheimer's disease progression

    Perez-Millan A, Falgas N, Bosch B et al. · Brain communications · 2026

  13. 0.89

    A multi-cohort study of longitudinal and cross-sectional Alzheimer's disease biomarkers in cognitively unimpaired older adults

    Xie L, Das SR, Li Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  14. 0.89

    Free-water imaging predicts cognitive decline and clinical progression in cognitively normal older adults

    He H, Zhang C, Yu D et al. · Journal of affective disorders · 2026

  15. 0.88

    Locus coeruleus degeneration is associated with cortical tau deposition and cognitive decline in older adults at familial risk of Alzheimer's disease

    Wearn A, Onuska KM, Shanks HRC et al. · bioRxiv : the preprint server for biology · 2025

  16. 0.88

    Locus coeruleus degeneration is associated with cortical tau deposition and cognitive decline in older adults at familial risk of Alzheimer's disease

    Wearn A, Onuska KM, Shanks HRC et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  17. 0.88

    Identifying Distinct Spatiotemporal Patterns of Juxtacortical Microstructure in Alzheimer Disease Using Diffusion MRI-derived Free Water Fraction

    Zhang J, Yang X, Wang Y et al. · Radiology · 2025

  18. 0.88

    Progression of fiber bundle damage in amnestic Alzheimer's disease and LATE: a 2-year fixel-based study

    Lebrun A, Leprince Y, Olivieri P et al. · GeroScience · 2026

  19. 0.87

    DTI-ALPS index-assessed glymphatic dysfunction mediates Alzheimer's cognitive decline via amyloid-beta-dependent pathways: multimodal PET/MRI study

    Zhang Y, Huang G, Geng J et al. · European journal of nuclear medicine and molecular imaging · 2025

  20. 0.87

    Dysfunction of the episodic memory network in the Alzheimer's disease cascade

    Lattmann R, Vockert N, Bernal J et al. · Nature communications · 2026

  21. 0.87

    Integrating plasma, MRI, and cognitive biomarkers for personalized prediction of decline across cognitive domains

    Moradi E, Dahnke R, Imani V et al. · Neurobiology of aging · 2025

  22. 0.87

    MRI-Derived AD Signature of Cortical Thinning and Plasma P-Tau217 for Predicting Alzheimer Dementia Among Community-Dwelling Older Adults

    Yu L, Wang T, Hansson O et al. · Neurology. Clinical practice · 2024

  23. 0.87

    Acceleration of Brain Atrophy and Progression From Normal Cognition to Mild Cognitive Impairment

    Uchida Y, Nishimaki K, Soldan A et al. · JAMA network open · 2024

  24. 0.86

    Spatiotemporal patterns of locus coeruleus integrity predict cortical tau and cognition

    Bueicheku E, Diez I, Kim CM et al. · Nature aging · 2024

  25. 0.86

    Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals

    Fujishima M, Kawasaki Y, Mitsuhashi T et al. · Alzheimer's research & therapy · 2024

  26. 0.86

    Multimodal Free-Water Imaging Links Cardiometabolic Risk to Periarterial Dysfunction and Amyloid Accumulation in Early Alzheimer's

    Chai Y, Zhang H, Kim AS et al. · Research square · 2026

  27. 0.86

    Prediction of alzheimer's disease time to dementia onset using cross-sectional data from spatiotemporal biomarker progression patterns

    Zhang T, Nie B, Liu H et al. · European journal of nuclear medicine and molecular imaging · 2026

  28. 0.86

    Choroid plexus remodeling linked to impaired CSF-mediated clearance and Alzheimer's disease progression

    Yin H, Deng Y, Lu Z et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  29. 0.85

    Multimodal and longitudinal characterization of distinct tau and atrophy clusters in Alzheimer's disease spectrum

    Rauchmann BS, Ersozlu E, Luedecke D et al. · Scientific reports · 2025

  30. 0.85

    Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging

    Wang Q, Schindler SE, Chen G et al. · Neurology · 2024

  31. 0.85

    APOE4 genotypes and the trajectory of biomarkers, neuroimaging, and cognitive measures in Alzheimer's Disease: A mixed-effects disease progression model

    Essenburg C, Ramanathan M · Journal of pharmacokinetics and pharmacodynamics · 2025

  32. 0.85

    Voxel-wise insights into early Alzheimer's disease pathology progression: the association with APOE and memory decline

    Wybitul M, Langer N, Hock C et al. · GeroScience · 2025

  33. 0.85

    Relationship between MRI brain-age heterogeneity, cognition, genetics and Alzheimer's disease neuropathology

    Antoniades M, Srinivasan D, Wen J et al. · EBioMedicine · 2024

  34. 0.85

    Integrated amyloid, neurodegeneration, and vascular biomarkers estimate the risk of dementia progression in mild cognitive impairment

    Lee WJ, Cho K, Kim GW · Journal of Alzheimer's disease : JAD · 2026

  35. 0.84

    Neurobiological correlates of longitudinal grey matter volume changes in preclinical Alzheimer's disease

    Pelkmans W, Cacciaglia R, Kassinopoulos M et al. · medRxiv : the preprint server for health sciences · 2025

  36. 0.84

    Can integration of Alzheimer's plasma biomarkers with MRI, cardiovascular, genetics, and lifestyle measures improve cognition prediction?

    Gebre RK, Graff-Radford J, Ramanan VK et al. · Brain communications · 2024

  37. 0.84

    Coupled sleep rhythm disruption predicts cognitive decline in Alzheimer's disease

    Wei T, Zhou J, Wang Z et al. · Science bulletin · 2025

  38. 0.83

    Cortical tau deposition promotes atrophy in connected white matter regions in Alzheimer's disease

    Pescoller J, Dewenter A, Dehsarvi A et al. · Brain : a journal of neurology · 2025

  39. 0.83

    Comprehensive evaluation of AT(N) imaging biomarkers for predicting cognitive decline

    Earnest T, Yang B, Kothapalli D et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  40. 0.83

    Utility of biomarkers in prediction of future cognition in Alzheimer's disease continuum changes over time

    Ramezannezhad E, Dehghani M · Journal of Alzheimer's disease : JAD · 2026

  41. 0.83

    Tau PET imaging as a mediator between glymphatic dysfunction and cognitive decline: a cross-sectional and longitudinal study

    Ko J, Son G, Seo HE et al. · European journal of nuclear medicine and molecular imaging · 2026

  42. 0.82

    Generating MRI-Derived CSF Proxy-Markers to Predict and Visualize Alzheimer's Disease Progression

    Abrol A, Calhoun VD · Human brain mapping · 2025

  43. 0.82

    Change points for dynamic biomarkers in the Alzheimer's disease pathological cascade: A 30-year cohort study

    Uchida Y, Nishimaki K, Soldan A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  44. 0.82

    Cortical thickness changes precede high levels of amyloid by at least 7 years

    Roe JM, Jagust WJ, Landau SM et al. · Nature neuroscience · 2026

  45. 0.82

    Multimodal prognostic modeling of individual cognitive trajectories to enhance trial efficiency in preclinical Alzheimer's disease

    Devanarayan V, Donohue MC, Sperling RA et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  46. 0.82

    Comprehensive evaluation of AT(N) imaging biomarkers for predicting cognition

    Earnest T, Yang B, Kothapalli D et al. · medRxiv : the preprint server for health sciences · 2024

  47. 0.81

    Cognitive and neurodegenerative trajectories of subjective cognitive decline according to baseline biomarkers: Results of the CoSCo study

    Hong YJ, Choi SH, Kim S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  48. 0.81

    Performance of Plasma Biomarkers Combined with Structural MRI to Identify Candidate Participants for Alzheimer's Disease-Modifying Therapy

    Manjavong M, Kang JM, Diaz A et al. · The journal of prevention of Alzheimer's disease · 2024

  49. 0.81

    Moderating role of triglycerides in the relationship between amyloid-beta, hippocampal atrophy, and cognitive decline in mild cognitive impairment and early Alzheimer's disease

    Seok JW, Kim K, Hwang S et al. · Frontiers in aging neuroscience · 2025

  50. 0.81

    Distinct patterns of spontaneous brain activity in mild cognitive impairment patients stratified by cerebrospinal fluid biomarkers

    Qi W, Zhang C, Feng Y et al. · Frontiers in aging neuroscience · 2026

  51. 0.81

    CSF p-tau Predicts Asymmetric Hippocampal Atrophy in Cognitively Unimpaired Older Adults

    Ghanbarian E, Zheng L, Qian T et al. · medRxiv : the preprint server for health sciences · 2026

  52. 0.80

    Cortical thickness changes precede high levels of amyloid by at least seven years

    Roe JM, Jagust WJ, Landau SM et al. · bioRxiv : the preprint server for biology · 2025

  53. 0.80

    Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients

    Matthews DC, Kinney JW, Ritter A et al. · Alzheimer's & dementia (New York, N. Y.) · 2024

  54. 0.79

    The coupling of global brain activity and cerebrospinal fluid flow as a potential predictive marker of brain amyloid-beta accumulation

    Tanaka Y, Kamagata K, Saito Y et al. · The journal of prevention of Alzheimer's disease · 2025

  55. 0.78

    Multimodal axes reveal individualized amyloid- beta , tau, and neurodegeneration coupling in aging and Alzheimer's disease

    Poulakis K, Ioannou K, Bezgin G et al. · medRxiv : the preprint server for health sciences · 2026

  56. 0.78

    Relationship between topological efficiency of white matter structural connectome and plasma biomarkers across the Alzheimer's disease continuum

    Zhang M, Chen H, Huang W et al. · Human brain mapping · 2024

  57. 0.78

    Association of Brain and Ventricular Boundary Shift Integral Measurements with CSF Biomarkers: A Case-Control Study

    Hosseini SF, Akbarabadi P, Noorani F et al. · Current Alzheimer research · 2025

  58. 0.77

    Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's disease

    Singleton EH, Mattsson-Carlgren N, Pichet Binette A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  59. 0.77

    The complementary role of automated brain volumetry to stratify ADNI participants within the ATN framework

    Ricchi I, Griffa A, Corredor-Jerez R et al. · Journal of Alzheimer's disease : JAD · 2025

  60. 0.76

    Neuroimaging-derived biological brain age and its associations with glial reactivity and synaptic dysfunction cerebrospinal fluid biomarkers

    Cumplido-Mayoral I, Sanchez-Benavides G, Vilor-Tejedor N et al. · Molecular psychiatry · 2025

  61. 0.76

    Associations of ischemic heart disease with brain glymphatic MRI indices and risk of Alzheimer's disease

    Wang ML, Yu MM, Sun Z et al. · The journal of prevention of Alzheimer's disease · 2025

  62. 0.76

    Association between antemortem plasma and structural MRI biomarkers and postmortem tau pathology in the Mayo Clinic Study of Aging

    Hu M, Moloney CM, Przybelski SA et al. · Alzheimer's research & therapy · 2025

  63. 0.76

    DTI-ALPS associations with regional amyloid deposition and glucose metabolism in mild cognitive impairment and Alzheimer's disease

    Yi C, Chen W, Shi X et al. · Journal of neuroradiology = Journal de neuroradiologie · 2026

  64. 0.76

    Impact of diabetes on the progression of Alzheimer's disease via trajectories of amyloid-tau-neurodegeneration (ATN) biomarkers

    Kim EW, Kim KY, Kim E · The journal of nutrition, health & aging · 2025

  65. 0.75

    Elevated serum sodium is linked to increased amyloid-dependent tau pathology, neurodegeneration, and cognitive impairment in Alzheimer's disease

    Chen YH, Wang ZB, Liu XP et al. · Journal of neurochemistry · 2025

  66. 0.74

    Divergent patterns of cognitive decline in preclinical Alzheimer's disease: implications for secondary prevention trials

    Li R, Langford O, Insel PS et al. · medRxiv : the preprint server for health sciences · 2026

  67. 0.74

    Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's Disease signature regions and predicted future tau deposition

    Hu Q, Shi M, Li Y et al. · Research square · 2024

  68. 0.73

    Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer's disease

    Tremblay C, Rahayel S, Pastor-Bernier A et al. · Brain communications · 2025

  69. 0.73

    The associations between attentional control, episodic memory, and Alzheimer's disease biomarkers of tau and neurodegeneration

    Stojanovic M, Millar PR, McKay NS et al. · Journal of Alzheimer's disease : JAD · 2025

  70. 0.73

    Onset ages of cerebrovascular disease and amyloid and effects on cognition in risk-enriched cohorts

    Du L, Planalp EM, Betthauser TJ et al. · Brain communications · 2025

  71. 0.73

    Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease

    Yim S, Gu Y, Kang H et al. · Clinical nuclear medicine · 2025

  72. 0.73

    Multidimensional MRI reveals cortical astrogliosis linked to dementia in Alzheimer's disease

    Barsoum S, Latimer CS, Nolan AL et al. · Brain communications · 2025

  73. 0.73

    Subtypes of brain change in aging and their associations with cognition and Alzheimer's disease biomarkers

    Capogna E, Sorensen O, Watne LO et al. · bioRxiv : the preprint server for biology · 2024

  74. 0.73

    A systematic comparison of ATN biomarkers for monitoring longitudinal cognitive changes in Alzheimer's disease

    Biel D, Steward A, Dewenter A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  75. 0.72

    Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers

    Gallego-Rudolf J, Wiesman AI, Yakoub Y et al. · Science advances · 2026

  76. 0.72

    Cognitive aging outcomes are related to both tau pathology and maintenance of cingulate cortex structure

    Pezzoli S, Giorgio J, Chen X et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  77. 0.72

    Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology

    Han F, Lee J, Chen X et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  78. 0.71

    Association of functional brain alterations with beta-amyloid, tau, and cognitive decline in Alzheimer's disease

    Guo W, Shao H, Zhang Y et al. · Alzheimer's research & therapy · 2026

  79. 0.71

    Cortical gray-white matter contrast alterations precede amyloid-beta positivity and macrostructural changes in older adults without dementia

    Pieperhoff L, Lorenzini L, Almeida F et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  80. 0.71

    Association of soluble tumor necrosis factor receptor 1 with tau pathology, brain atrophy, and cognitive decline: a longitudinal study

    Zhang Y, Sun L, Zhao Y et al. · BMC medicine · 2026

  81. 0.71

    Subtypes of brain change in aging and their associations with cognition and Alzheimer's disease biomarkers

    Capogna E, Sorensen O, Watne LO et al. · Neurobiology of aging · 2025

  82. 0.70

    The potential utility of arterial spin labeling in predicting brain amyloidosis

    Kazemzadeh K, Naseri N, Mombeini M et al. · Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2025

  83. 0.70

    Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer's disease

    Sewell KR, Doecke JD, Xiong C et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  84. 0.70

    Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease

    Argiris G, Akinci M, Pena-Gomez C et al. · Alzheimer's research & therapy · 2024

  85. 0.70

    gamma-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)

    Schultz SA, Liu L, Schultz AP et al. · The Lancet. Neurology · 2024

  86. 0.70

    Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults

    Lu K, Baker J, Nicholas JM et al. · Brain : a journal of neurology · 2025

  87. 0.69

    Associations of plasma biomarkers with cerebral perfusion and structure in Alzheimer's disease

    He Y, Liu X, Liu F et al. · Translational psychiatry · 2025

  88. 0.69

    Chronic pain as a risk factor for Alzheimer's disease pathology: a longitudinal ADNI study

    Bell TR, Franz CE, Fennema-Notestine C et al. · Alzheimer's research & therapy · 2026

  89. 0.69

    A Multimodal Latent Severity Axis for Alzheimer's Disease: Probabilistic PCA, Bayesian Trajectories, and Stage-Aware Timing Effects

    Haji B, Tahami Monfared AA · Neurology and therapy · 2026

  90. 0.68

    Clinical and Pathological Progression of Awareness Trajectories in Preclinical Alzheimer's Disease

    Lopez-Martos D, Sanchez-Benavides G, Grau-Rivera O et al. · medRxiv : the preprint server for health sciences · 2026

  91. 0.66

    Cross-sectional and prognostic associations of baseline [(18)F]GTP1 tau PET signal and white matter lesion volumes for cognitive and functional decline in prodromal-to-mild Alzheimer's disease

    Ruiz-Uribe NE, Manser P, Butcher B et al. · Journal of Alzheimer's disease : JAD · 2025

  92. 0.66

    Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers

    Gallego-Rudolf J, Wiesman AI, Yakoub Y et al. · medRxiv : the preprint server for health sciences · 2025

  93. 0.66

    Associations of obstructive sleep apnea with A/T/N biomarkers, neuroimaging abnormalities, neurodegenerative progression, and CPAP-related changes in Alzheimer's disease

    Zheng W, Zhou Y, Lu M et al. · Sleep medicine · 2026

  94. 0.66

    Structural MRI across lifespan reveals differential thalamic trajectories in Down syndrome

    Shaikh M, Fletcher P, Zaman S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  95. 0.66

    The relationships between cerebrospinal fluid neurofilament light chain and hippocampal atrophy with cognitive decline

    Singh RK, Bekena S, Damera N et al. · Journal of Alzheimer's disease : JAD · 2025

  96. 0.66

    Multimodal biomarkers to predict dementia-free survival and cognitive decline in mild cognitive impairment with Lewy bodies

    Hasoon J, Hamilton CA, Firbank M et al. · Parkinsonism & related disorders · 2026

  97. 0.66

    Mesial temporal tau pathology impacts basal forebrain degeneration in early Alzheimer's disease

    Xia Y, Dean MW, Bourgeat P et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  98. 0.66

    Divergent neurodegeneration associations with choroid plexus volume and degree of calcification in cognitively normal APOE epsilon4 carriers and non-carriers

    Ozsahin I, Wang X, Zhou L et al. · Scientific reports · 2025

  99. 0.64

    Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease

    Meeker KL, Luckett PH, Barthelemy NR et al. · Brain communications · 2024

  100. 0.64

    Tau mediates the impact of amyloid and vascular disease burden on the trajectory of clinical symptoms

    Du L, Langhough RE, Hermann BP et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  101. 0.64

    Effect of Genetic Risk on the Relationship Between rs-fMRI Complexity and Tau and Amyloid PET in Alzheimer's Disease

    Jann K, Cen S, Santos M et al. · Journal of Alzheimer's disease : JAD · 2024

  102. 0.63

    Brain glymphatic fluid mapping in Alzheimer's disease: a human MRI and PET study

    Zhou L, Nguyen TD, Chiang GC et al. · Brain communications · 2025

  103. 0.63

    Distinctive volumetric associations between plasma p-tau181 and hippocampal formation structures across the Alzheimer's disease continuum

    Rich A, Oh H · Journal of Alzheimer's disease : JAD · 2025

  104. 0.63

    The CSF p-tau/beta-amyloid 42 ratio correlates with brain structure and fibrillary beta-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease

    Cacciaglia R, Shekari M, Salvado G et al. · Brain communications · 2025

  105. 0.62

    Spatiotemporal dynamics of tau pathology and neurodegeneration in Medial Temporal Lobe (MTL) subregions across alzheimer's disease progression: A multimodal imaging study using second-generation tracer [(18)F]MK-6240

    Piao S, Li B, Wang J et al. · European journal of nuclear medicine and molecular imaging · 2026

  106. 0.62

    Resiliency to Alzheimer's disease neuropathology can be distinguished from dementia using cortical astrogliosis imaging

    Barsoum S, Latimer CS, Nolan AL et al. · bioRxiv : the preprint server for biology · 2024

  107. 0.61

    Amyloid, Tau, and APOE in Alzheimer's Disease: Impact on White Matter Tracts

    Chandio BQ, Villalon-Reina JE, Nir TM et al. · bioRxiv : the preprint server for biology · 2024

  108. 0.61

    Retrospective analysis of Braak stage- and APOE4 allele-dependent associations between MR spectroscopy and markers of tau and neurodegeneration in cognitively unimpaired elderly

    Chen AM, Gajdosik M, Ahmed W et al. · NeuroImage · 2024

  109. 0.61

    Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer's and Lewy body disease

    Duong MT, Das SR, Khandelwal P et al. · Brain : a journal of neurology · 2025

  110. 0.60

    Personalized whole-brain neural mass models reveal combined Abeta and tau hyperexcitable influences in Alzheimer's disease

    Sanchez-Rodriguez LM, Bezgin G, Carbonell F et al. · Communications biology · 2024

  111. 0.60

    Morphometry of medial temporal lobe subregions using high-resolution T2-weighted MRI in ADNI3: Why, how, and what's next?

    Yushkevich PA, Ittyerah R, Li Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  112. 0.60

    Divergent effects of age on imaging-based ATN biomarkers and cognition in Alzheimer's disease

    Frings L, Hellwig S, Brumberg J et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2025

  113. 0.60

    Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging

    Doering S, McCullough A, Gordon BA et al. · EBioMedicine · 2024

  114. 0.60

    Longitudinal trajectories of divergent cortical tau patterns in preclinical Alzheimer's disease

    Young CB, Sheng J, Winer JR et al. · Brain : a journal of neurology · 2026

  115. 0.60

    Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects

    Leng F, Hinz R, Gentleman S et al. · Journal of Alzheimer's disease : JAD · 2024

  116. 0.60

    Elevated plasma p-tau231 is associated with reduced generalization and medial temporal lobe dynamic network flexibility among healthy older African Americans

    Budak M, Fausto BA, Osiecka Z et al. · Alzheimer's research & therapy · 2024

  117. 0.60

    Real world clinical practice of lecanemab at PUMCH dementia cohort: focus on dynamic imaging and biomarker evolution

    Mao C, Wang W, Huang X et al. · Alzheimer's research & therapy · 2026

  118. 0.59

    Plasma p-tau181 and GFAP reflect 7T MR-derived changes in Alzheimer's disease: A longitudinal study of structural and functional MRI and MRS

    Goschel L, Dell'Orco A, Fillmer A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  119. 0.57

    Computational Risk Stratification of Preclinical Alzheimer's in Younger Adults

    Anyaiwe O, Nataraj N, Gudikandula BS · Diagnostics (Basel, Switzerland) · 2025

  120. 0.56

    Association and interaction of blood homocysteine and p-tau217 levels with temporal cortical thinning and cognitive impairment in Alzheimer's disease

    Wang Q, Zhong X, Gao P et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  121. 0.56

    Association of Cortical Free Water With Brain Tau Tangle Load in the Alzheimer Disease Continuum

    Hall BJ, Aumont E, Hosseini SA et al. · Neurology · 2026

  122. 0.56

    Structural MRI signature predicts tau staging in Alzheimer's disease

    Pulze M, Garbarino S, Lorenzini L et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  123. 0.56

    Are the factors associated with cognitive performance generalizable across cohorts?

    Liu P, Harrison TM, Snyder HM et al. · NeuroImage. Clinical · 2026

  124. 0.56

    Sex/gender effects of glial reactivity on preclinical Alzheimer's disease pathology

    Vila-Castelar C, Akinci M, Palpatzis E et al. · Molecular psychiatry · 2025

  125. 0.56

    Brain MRI signatures across sex and CSF Alzheimer's disease biomarkers

    Cheng Y, He Y, Gopinath K et al. · Brain communications · 2025

  126. 0.55

    Neurodegeneration biomarkers in Alzheimer's disease: axonal density index expands the "N" in the AT(N) framework

    Flaherty R, Masurkar AV · The Journal of clinical investigation · 2026

  127. 0.55

    Limited utility of imaging-based (N) markers in predicting cerebral spinal fluid Alzheimer's disease biomarker positivity in lecanemab-eligible mild cognitive impairment

    Kuroda T, Mori Y, Shoji D et al. · Frontiers in neurology · 2025

  128. 0.54

    Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History study

    Pieperhoff L, Lorenzini L, Mastenbroek S et al. · NeuroImage. Clinical · 2025

  129. 0.54

    Using CA1 rather than the whole hippocampus to capture tau-PET Braak stage II

    Aumont E, Trudel L, Hall BJ et al. · European journal of nuclear medicine and molecular imaging · 2026

  130. 0.54

    Tau accumulation and atrophy predict amyloid independent cognitive decline in aging

    Fonseca CS, Baker SL, Dobyns L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  131. 0.54

    Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease

    Zamani J, Vahid A, Avelar-Pereira B et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  132. 0.53

    Baseline cortical amyloid-beta levels are associated with subsequent study-partner-rated apathy in community-dwelling older adults

    Munro CE, Beltran J, Palmer P et al. · Journal of Alzheimer's disease : JAD · 2026

  133. 0.53

    Estimating the time course of biomarker changes in Alzheimer's disease

    Raket LL, Binette AP, Mattsson-Carlgren N et al. · Brain : a journal of neurology · 2026

  134. 0.53

    Spatial amyloid-informed multimodal brain age as an early marker of Alzheimer's-related vulnerability and risk stratification

    Cui L, Wang QM, Zhang Z et al. · The journal of prevention of Alzheimer's disease · 2026

  135. 0.53

    Clinical impact of amyloid PET in memory clinic: A 2-year longitudinal real-world study in Taiwan

    Chou CJ, Chuang YF, Chiu YL et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  136. 0.53

    Intracranial stenosis and longitudinal progression of Alzheimer's disease pathologies

    Kang KM, Park C, Nam H et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  137. 0.52

    The Moderating Effect of Serum Vitamin D on the Relationship between Beta-amyloid Deposition and Neurodegeneration

    Park J, Byun MS, Yi D et al. · Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024

  138. 0.52

    Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-beta 42/40 positivity

    Pyun JM, Park YH, Youn YC et al. · Translational psychiatry · 2024

  139. 0.52

    Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial

    Bittner T, Lopera F, Rios-Romenets S et al. · EBioMedicine · 2026

  140. 0.52

    Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer's Disease Trajectory?

    Nowell J, Raza S, Livingston NR et al. · Journal of Alzheimer's disease : JAD · 2024

  141. 0.51

    Neurobiological markers across joint profiles of subjective cognitive decline and objective cognitive function in older adults

    Wan L, Kang C, Harrison R et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  142. 0.51

    Multilayer Integration of Networks Toolbox (MINT)

    Sarraf S, Avelar-Pereira B, Hosseini SMH · Communications biology · 2025

  143. 0.50

    Cellular circadian period and its deviation associate with Alzheimer's pathology and brain aging in cognitively impaired older adults

    Roh HW, Seo SW, Choi SH et al. · Proceedings of the National Academy of Sciences of the United States of America · 2026

  144. 0.50

    Lower Plasma Serotonin is Associated with Higher Amyloid Burden, Hippocampal Atrophy, and Cognitive decline in Alzheimer's Disease: A 24-Month Longitudinal Study

    Han Y, Liu L, Chang L et al. · Journal of molecular neuroscience : MN · 2026

  145. 0.50

    Hippocampal 1H-MR spectroscopy metabolites are linked to CSF tau pathology in cognitively unimpaired older adults along the Alzheimer's continuum

    Lingad JN, Vanderlip CR, Wright S et al. · Neurobiology of aging · 2026

03machine learning · model112편

  1. 0.95

    A radiomics model predicts progression from mild cognitive impairment to alzheimer's disease using structural MRI

    Li Y, Yi P, Jin M et al. · Scientific reports · 2025

  2. 0.95

    Longitudinal structural MRI-based deep learning and radiomics features for predicting Alzheimer's disease progression

    Aghajanian S, Mohammadifard F, Mohammadi I et al. · Alzheimer's research & therapy · 2025

  3. 0.94

    MRI Radiomics Nomogram for Predicting Disease Transition Time and Risk Stratification in Preclinical Alzheimer's Disease

    Lin S, Xue M, Sun J et al. · Academic radiology · 2025

  4. 0.94

    Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms

    Arvidsson I, Strandberg O, Palmqvist S et al. · Alzheimer's research & therapy · 2024

  5. 0.94

    Use of magnetic resonance structural imaging to identify disease progression in patients with mild cognitive impairment: A voxel-based morphometry and surface-based morphometry study

    Xu Y, Zhang Z, Peng J et al. · Neuroscience · 2025

  6. 0.94

    A Predictive Model of the Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment Based on the MRI Enlarged Perivascular Spaces

    Chen J, Yang J, Shen D et al. · Journal of Alzheimer's disease : JAD · 2024

  7. 0.93

    Evaluating conversion from mild cognitive impairment to Alzheimer's disease with structural MRI: a machine learning study

    Vecchio D, Piras F, Natalizi F et al. · Brain communications · 2025

  8. 0.93

    Comparison of Brain Age With Standard MRI Assessment for Dementia Risk Stratification in Subjective and Mild Cognitive Impairment

    De Vries S, Farkas K, Rhodius-Meester HFM et al. · Neurology · 2026

  9. 0.93

    Longitudinal Analysis of Amyloid PET and Brain MRI for Predicting Conversion from Mild Cognitive Impairment to Alzheimer's Disease: Findings from the ADNI Cohort

    Kim DH · Tomography (Ann Arbor, Mich.) · 2025

  10. 0.93

    Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns

    Lerch O, Ferreira D, Stomrud E et al. · Alzheimer's research & therapy · 2024

  11. 0.93

    Predicting MCI-to-Alzheimer's Conversion: A Systematic Benchmark of Classical, Machine Learning, and Deep Survival Models

    Santa NA, Daza-Santacoloma G, Serna WS · Diagnostics (Basel, Switzerland) · 2026

  12. 0.93

    A score based on MRI imaging variables can predict time to moderate progression in mild cognitive impairment: Multimodal data integration study

    Jodlowska-Siewert E, Liu L, Yang K et al. · Journal of Alzheimer's disease : JAD · 2026

  13. 0.92

    Predicting long-term progression of Alzheimer's disease using a multimodal deep learning model incorporating interaction effects

    Wang Y, Gao R, Wei T et al. · Journal of translational medicine · 2024

  14. 0.92

    A dual space MRI radiomic network signature for risk stratification and subtyping of mild cognitive impairment

    Xiong D, Liu M, Xie J et al. · iScience · 2026

  15. 0.92

    Machine-learning prediction and risk stratification of 12-month cognitive decline in Alzheimer's disease using routine clinical and MRI data

    Geng Y, Zhang H · Scientific reports · 2026

  16. 0.92

    Elevated BrainAGE precedes cognitive impairment and improves prediction of future cognitive decline

    Moradi E, Dahnke R, Gaser C et al. · medRxiv : the preprint server for health sciences · 2026

  17. 0.92

    Decreased brain interstitial fluid dynamics is associated with risk of Alzheimer's disease-related cognitive decline

    Guo Y, Liu T, Chen H et al. · Brain research bulletin · 2025

  18. 0.92

    Innovative Multivariable Model Combining MRI Radiomics and Plasma Indexes Predicts Alzheimer's Disease Conversion: Evidence from a 2-Cohort Longitudinal Study

    Yu X, Sun X, Wei M et al. · Research (Washington, D.C.) · 2024

  19. 0.92

    Interpretable MRI-Based Deep Learning for Alzheimer's Risk and Progression

    Lu B, Chen YR, Li RX et al. · medRxiv : the preprint server for health sciences · 2025

  20. 0.92

    Predicting the progression of MCI and Alzheimer's disease on structural brain integrity and other features with machine learning

    Mieling M, Yousuf M, Bunzeck N · GeroScience · 2026

  21. 0.91

    Integrating standard and native spaces for radiomics and brain network analysis in Alzheimer's disease diagnosis and prognosis

    Xiong D, Liu M, Liu Z et al. · Journal of neurology · 2026

  22. 0.91

    Predicting Future Brain Atrophy Based on Longitudinal MRI

    Hadji M, Moradi E, Tohka J · medRxiv : the preprint server for health sciences · 2025

  23. 0.91

    Decoding Choroid Plexus Pathology in Alzheimer's Disease: A Longitudinal Radiomics Approach for Prodromal Identification and Risk Stratification

    Yin F, Wang X, Chen X et al. · CNS neuroscience & therapeutics · 2026

  24. 0.91

    Clinical utility of diffusion MRI-derived measures of cortical microstructure in a real-world memory clinic setting

    Torso M, Fumagalli G, Ridgway GR et al. · Annals of clinical and translational neurology · 2024

  25. 0.91

    Robust and interpretable AI-guided marker for early dementia prediction in real-world clinical settings

    Lee LY, Vaghari D, Burkhart MC et al. · EClinicalMedicine · 2024

  26. 0.91

    Multimodal prediction of MCI-to-dementia conversion over a two-year window

    Simkhada B, Liang TY, Cui X et al. · GeroScience · 2026

  27. 0.91

    Standardized Comparison of Clinical, Cognitive, Genetic, Neuroimaging, and Fluid Biomarkers for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer's Disease

    Choe S · medRxiv : the preprint server for health sciences · 2026

  28. 0.91

    Integrated cerebellar radiomic-network model for predicting mild cognitive impairment in Alzheimer's disease

    Chen Y, Qi Y, Hu Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  29. 0.91

    Early prediction of Alzheimer's disease using artificial intelligence and cortical features on T1WI sequences

    Zeng R, Yang B, Wu F et al. · Frontiers in neurology · 2025

  30. 0.91

    Predicting Conversion from SCD to MCI: A Machine Learning Study

    Kamal F, Metz A, Chadwick K et al. · medRxiv : the preprint server for health sciences · 2026

  31. 0.90

    Individualized prediction of transition from subjective cognitive decline to mild cognitive impairment based on multimodal MRI: a 10-year follow-up study

    Le X, Feng J, Yu X et al. · The journal of prevention of Alzheimer's disease · 2026

  32. 0.90

    Early Diagnosis of Alzheimer's: Machine Learning Analysis Leveraging Structural MRI

    Dar SA, Imtiaz N, Dar RA · Current Alzheimer research · 2026

  33. 0.90

    Tracking early cognitive decline in preclinical AD with brain MRI similarity

    Sun J, Zufiria-Gerboles B, Passaretti M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  34. 0.90

    Structural, Functional and Cognitive Validation of a Deep-Learning MCI-to-AD Conversion Model in OASIS-3

    Fin S, Moayedikia A · medRxiv : the preprint server for health sciences · 2026

  35. 0.90

    Interpretable multivariate survival models: Improving predictions for conversion from mild cognitive impairment to Alzheimer's disease via data fusion and machine learning

    Rosales-Gurmendi DS, Fumagal-Gonzalez GA, Orozco J et al. · PloS one · 2026

  36. 0.90

    Risk factors and predictive models in the progression from MCI to Alzheimer's disease

    Li C, Wang S, Xia Y et al. · Neuroscience · 2025

  37. 0.90

    Baseline multimodal imaging to predict longitudinal clinical decline in atypical Alzheimer's disease

    Coburn RP, Graff-Radford J, Machulda MM et al. · Cortex; a journal devoted to the study of the nervous system and behavior · 2024

  38. 0.89

    Predicting future cognitive impairment in preclinical Alzheimer's disease using amyloid PET and MRI: A multisite machine learning study

    Yang B, Earnest T, Bilgel M et al. · Neurobiology of aging · 2026

  39. 0.89

    Prognostic model for predicting Alzheimer's disease conversion using functional connectome manifolds

    Kim S, Kim M, Lee JE et al. · Alzheimer's research & therapy · 2024

  40. 0.89

    Predicting future brain atrophy based on longitudinal MRI

    Hadji M, Moradi E, Tohka J · Journal of Alzheimer's disease : JAD · 2026

  41. 0.88

    Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage

    Yue L, Pan Y, Li W et al. · The journal of prevention of Alzheimer's disease · 2025

  42. 0.88

    A prediction model of dementia conversion for mild cognitive impairment by combining plasma pTau181 and structural imaging features

    Li TR, Li BL, Zhong J et al. · CNS neuroscience & therapeutics · 2024

  43. 0.88

    Predicting future cognitive impairment in preclinical Alzheimer's disease using multimodal imaging: a multisite machine learning study

    Yang B, Earnest T, Bilgel M et al. · medRxiv : the preprint server for health sciences · 2025

  44. 0.88

    Deep learning model for individualized trajectory prediction of clinical outcomes in mild cognitive impairment

    Jung W, Kim SE, Kim JP et al. · Frontiers in aging neuroscience · 2024

  45. 0.88

    Deep survival modeling to predict future cognitive impairment in unimpaired adults

    Imms P, Wang H, Bhattacharya S et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026

  46. 0.87

    Prediction of future dementia among patients with mild cognitive impairment (MCI) by integrating multimodal clinical data

    Cirincione A, Lynch K, Bennett J et al. · Heliyon · 2024

  47. 0.87

    Classification and prediction of Alzheimer's disease stages and conversion from mild cognitive impairment based on multimodal data fusion

    Wang Y, Li H, Wang Y et al. · Frontiers in aging neuroscience · 2026

  48. 0.87

    Systematic Modality Ablation of Multimodal Machine Learning for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer's Disease

    Choe S · medRxiv : the preprint server for health sciences · 2026

  49. 0.86

    Integration of glymphatic system function and hippocampal radiomics for diagnosis and conversion prediction of Alzheimer's disease

    Mao X, Zhang D, Ying D et al. · BMC medical imaging · 2026

  50. 0.86

    Pattern of heterogeneity in normal brain ageing: screening for mild cognitive impairment and its risk of progression with a radiomics model

    Yan Y, He X, Xu Y et al. · Age and ageing · 2024

  51. 0.86

    Comparative Prognostic Performance of Hippocampal Volume and Plasma Biomarkers in Amyloid-Negative Subjective Cognitive Decline: A Four-Year Follow-up

    Yoon B, Lee HJ, Hong YJ et al. · Journal of clinical neurology (Seoul, Korea) · 2026

  52. 0.86

    Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes

    Gao Z, Zhu W, Li Y et al. · Journal of Alzheimer's disease : JAD · 2024

  53. 0.86

    Quantifying generalization error in machine learning prediction of cognitive decline

    Huppi RM, Langer N, Hebling Vieira B · The journal of prevention of Alzheimer's disease · 2026

  54. 0.86

    Stratifying heterogeneity in mild cognitive impairment: A multimodal subtype and stage inference approach

    Rodolfo CC, Vinicius SR, Francesca B et al. · Neurobiology of aging · 2026

  55. 0.85

    Imaging-genetics-based dementia risk prediction using deep survival neural networks in the Rotterdam Study

    Yu J, Rosbergen MT, Wolters FJ et al. · Research square · 2025

  56. 0.85

    Predicting Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using a Vision Transformer and Hippocampal MRI Slices

    Seiger R, Fierlinger P · Bioengineering (Basel, Switzerland) · 2026

  57. 0.84

    The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline

    Rivera Sanchez M, Mastenbroek SE, Janelidze S et al. · Neurology · 2026

  58. 0.84

    Clinical pathways matter for multimodal deep learning in early Alzheimer's disease detection

    Lu Y, Hammonds SK, Fernandez-Quilez A · Scientific reports · 2026

  59. 0.84

    Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imaging

    Dadu A, Ta M, Tustison NJ et al. · medRxiv : the preprint server for health sciences · 2024

  60. 0.83

    Machine learning prediction prior to onset of mild cognitive impairment using T1-weighted magnetic resonance imaging radiomic of the hippocampus

    Zhan S, Wang J, Dong J et al. · Asian journal of psychiatry · 2025

  61. 0.82

    Predicting conversion from mild cognitive impairment to Alzheimer's disease: a multimodal approach

    Agostinho D, Simoes M, Castelo-Branco M · Brain communications · 2024

  62. 0.81

    Machine Learning Approaches for Predicting Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment

    Gelir F, Akan T, Alp S et al. · Journal of medical and biological engineering · 2025

  63. 0.80

    A Machine Learning Approach to Predict Cognitive Decline in Alzheimer Disease Clinical Trials

    Nallapu BT, Petersen KK, Qian T et al. · Neurology · 2025

  64. 0.80

    MRI-informed machine learning-driven brain age models for classifying mild cognitive impairment converters

    Lu H, Li J · Journal of central nervous system disease · 2024

  65. 0.80

    AI-based staging, causal hypothesis and progression of subjects at risk of Alzheimer's disease: a multicenter study

    Aresta S, Nemni R, Zanardo M et al. · Frontiers in neurology · 2025

  66. 0.79

    Temporalis muscle biomarkers from routine brain MRI and risk of dementia in two independent cohorts

    Moradi K, Hadidchi R, Majbri A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  67. 0.79

    Predicting dementia risk using neuroimaging and cognitive assessment

    Wang Y, Guiler W, Patel A et al. · JAR life · 2025

  68. 0.79

    Imaging-genetics-based dementia risk prediction using deep survival neural networks in the Rotterdam Study

    Yu J, Rosbergen MT, Wolters FJ et al. · Scientific reports · 2026

  69. 0.78

    Towards the development of a management protocol for subjective cognitive decline: Insights from a cross-sectional and longitudinal analysis of multimodal data from a memory clinic

    Mazzeo S, Lassi M, Padiglioni S et al. · Journal of Alzheimer's disease : JAD · 2026

  70. 0.78

    Predicting Continuous Cognitive Decline: The Generalizability of a Multimodal Machine Learning Approach Including Structural MRI and Non-Brain Data

    Huppi RM, Langer N, Vieira BH · medRxiv : the preprint server for health sciences · 2026

  71. 0.77

    Exploring the neuromagnetic signatures of cognitive decline from mild cognitive impairment to Alzheimer's disease dementia

    Gaubert S, Garces P, Hipp J et al. · EBioMedicine · 2025

  72. 0.77

    Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia

    van der Veere PJ, Hoogland J, Visser LNC et al. · Neurology · 2024

  73. 0.77

    Classifying cognitive impairment based on FDG-PET and combined T1-MRI and rs-fMRI: An ADNI study

    Jahani I, Jahani A, Delrobaei M et al. · Journal of Alzheimer's disease : JAD · 2025

  74. 0.76

    Individualized and Biomarker-Based Prognosis of Longitudinal Cognitive Decline in Early Symptomatic Alzheimer's Disease

    Wang X, Ye T, Huang Z et al. · Journal of Alzheimer's disease reports · 2024

  75. 0.76

    Predicting cognitive change using functional, structural, and neuropsychological predictors

    Decarie-Labbe L, Mellah S, Dialahy IZ et al. · Brain communications · 2025

  76. 0.76

    MRI-based Radiomics and volumetrics for predicting the onset of Alzheimer's Disease with explainable machine learning

    Bloch L, Borys K, Nensa F et al. · NeuroImage · 2026

  77. 0.76

    Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals

    Moradi E, Prakash M, Hall A et al. · Alzheimer's research & therapy · 2024

  78. 0.76

    A machine learning approach for identifying anatomical biomarkers of early mild cognitive impairment

    Ahmad AL, Sanchez-Bornot JM, Sotero RC et al. · PeerJ · 2024

  79. 0.75

    Multi-modal machine learning approach for early detection of neurodegenerative diseases leveraging brain MRI and wearable sensor data

    Li A, Lian J, Vardhanabhuti V · PLOS digital health · 2025

  80. 0.75

    Brain Age Is Associated with Cognitive Outcomes of Cholinesterase Inhibitor Treatment in Patients with Mild Cognitive Impairment

    Tseng WYI, Hsu YC, Huang LK et al. · Journal of Alzheimer's disease : JAD · 2024

  81. 0.75

    Statistical Method for Identification of Alzheimer Disease With Multimodal Predictive Markers Mild Cognitive Impairment

    Zarei S, Shalbaf R, Shalbaf A · Basic and clinical neuroscience · 2025

  82. 0.74

    Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data

    Wittens MMJ, Sima DM, Brys A et al. · Alzheimer's research & therapy · 2025

  83. 0.73

    A computational model to describe multi-regional brain architecture during neurodegeneration in Alzheimer's disease

    Li X, Rockall AG, Edison P et al. · Scientific reports · 2026

  84. 0.73

    A multimodal machine learning model integrating plasma biomarkers and MRI metrics for non-invasive prediction of amyloid-beta pathology in mild cognitive impairment

    Fang Q, Guo Y, Chen L et al. · Journal of Alzheimer's disease : JAD · 2026

  85. 0.73

    Predicting the Progression of Mild Cognitive Impairment to Alzheimer's Dementia Using Recurrent Neural Networks With a Series of Neuropsychological Tests

    Park C, Joo G, Roh M et al. · Journal of clinical neurology (Seoul, Korea) · 2024

  86. 0.72

    Real-World Multimodal Machine Learning for Risk Enrichment Across the Alzheimer's Disease Spectrum

    Bulbul NG, Baytas IM, Kavalci E et al. · Journal of clinical medicine · 2026

  87. 0.71

    Machine learning-enhanced screening funnel for clinical trials in Alzheimer's disease

    Gladstein S, Yang L, Wooten D et al. · Alzheimer's & dementia (New York, N. Y.) · 2025

  88. 0.70

    Comparative evaluation of automated MRI-based brain volumetry software for estimating cognitive domains in early Alzheimer's disease

    Lim CY, Sim Y, Lee YG et al. · BMC medical imaging · 2026

  89. 0.70

    Classification of tau status with machine learning models in amyloid-positive cohorts

    Lin YC, Chiu SC, Massey R et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  90. 0.69

    Multidomain Analysis of Clinical Cognitive Assessments and Imaging Data in Alzheimer's Disease Accurately Predicts Disease Stage and Grade Independent of Amyloid and Tau

    Chong Chie JAKH, Persohn SA, Simcox OR et al. · bioRxiv : the preprint server for biology · 2026

  91. 0.69

    Predicting the reversion from mild cognitive impairment to normal cognition based on magnetic resonance imaging, clinical, and neuropsychological examinations

    Yu HH, Tan CC, Huang SJ et al. · Journal of affective disorders · 2024

  92. 0.69

    Exploring the Value of MRI Measurement of Hippocampal Volume for Predicting the Occurrence and Progression of Alzheimer's Disease Based on Artificial Intelligence Deep Learning Technology and Evidence-Based Medicine Meta-Analysis

    Zhou J, Zhao M, Yang Z et al. · Journal of Alzheimer's disease : JAD · 2024

  93. 0.68

    Dynamic and Static Structure-Function Coupling With Machine Learning for the Early Detection of Alzheimer's Disease

    Wu H, Lu Y, Wang L et al. · Human brain mapping · 2025

  94. 0.68

    Interpretable Machine Learning for Risk Stratification of Hippocampal Atrophy in Alzheimer's Disease Using CSF Erythrocyte Load and Clinical Data

    Christodoulou RC, Vamvouras G, Papageorgiou PS et al. · Biomedicines · 2025

  95. 0.67

    Mild cognitive impairment-to-Alzheimer's dementia progression risk: the contribution of the Interceptor project

    Lombardo FL, Caraglia N, Lorenzini P et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  96. 0.67

    AI-powered evaluation of dementia severity based on clinical data and visual scoring systems (MTA, ERICA, GCA) from MRI

    Naing LT, Kunapinun A, Dailey MN et al. · Scientific reports · 2026

  97. 0.66

    A multi-stage feature selection method to improve classification of potential super-agers and cognitive decliners using structural brain MRI data-a UK biobank study

    Mohammadiarvejeh P, Fili M, Dawson A et al. · GeroScience · 2025

  98. 0.66

    T1-Weighted Imaging-Based Hippocampal Radiomics in the Diagnosis of Alzheimer's Disease

    Yin TT, Cao MH, Yu JC et al. · Academic radiology · 2024

  99. 0.63

    Brain age as a biomarker for pathological versus healthy ageing - a REMEMBER study

    Wittens MMJ, Denissen S, Sima DM et al. · Alzheimer's research & therapy · 2024

  100. 0.63

    Exploring the power of MRI and clinical measures in predicting AD neuropathology

    Kamal F, Morrison C, Oliver MD et al. · GeroScience · 2025

  101. 0.62

    Multimodal Dementia Screening from Brain Magnetic Resonance Imaging and Conversational Speech

    Lankenau KM, Brause E, Schill J et al. · Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2024

  102. 0.62

    Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment

    Nallapu BT, Petersen KK, Lipton RB et al. · Journal of Alzheimer's disease : JAD · 2024

  103. 0.59

    Predicting the apolipoprotein E epsilon4 allele carrier status based on gray matter volumes and cognitive function

    Kim HG, Tian Y, Jung SM et al. · Brain and behavior · 2024

  104. 0.58

    Brain age prediction in a multiethnic Asian population: A comparison of machine learning algorithms and their application for early-stage cognitive impairment diagnosis

    Piquero Lanciego C, Tan WY, Tee M et al. · Journal of Alzheimer's disease : JAD · 2026

  105. 0.57

    Predicting Autopsy-Confirmed Neuropathology across Clinical, Neuroimaging, and CSF Biomarkers using Machine Learning

    Patterson C, Chattopadhyay T, Thomopoulos SI et al. · bioRxiv : the preprint server for biology · 2026

  106. 0.57

    Beyond brain scans: verbal memory testing as an efficient cognitive biomarker for preclinical Alzheimer's disease

    Elkana O, Segal O, Beheshti I · Neuroscience · 2026

  107. 0.55

    Enriched resting-state EEG prediction of cognitive decline in prodromal Alzheimer's disease: a machine-learning approach

    Babiloni C, Lopez S, Noce G et al. · Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2026

  108. 0.53

    Early diagnosis of Alzheimer's disease and mild cognitive impairment using MRI analysis and machine learning algorithms

    Givian H, Calbimonte JP · Discover applied sciences · 2025

  109. 0.53

    Deep-learning based multi-modal models for brain age, cognition and amyloid pathology prediction

    Wang C, Zhang W, Ni M et al. · Alzheimer's research & therapy · 2025

  110. 0.52

    From Microbleeds to Iron: AI Prediction of Cerebrospinal Fluid Erythrocyte Load in Alzheimer's Disease

    Christodoulou RC, Vamvouras G, Sarquis MD et al. · Journal of clinical medicine · 2025

  111. 0.51

    MRI radiomics combined with machine learning for diagnosing mild cognitive impairment: a focus on the cerebellar gray and white matter

    Lin A, Chen Y, Chen Y et al. · Frontiers in aging neuroscience · 2024

  112. 0.50

    Machine Learning-Driven Prediction of Brain Age for Alzheimer's Risk: APOE4 Genotype and Gender Effects

    Woods C, Xing X, Khanal S et al. · Bioengineering (Basel, Switzerland) · 2024

04framework · learning91편

  1. 0.93

    Alzheimer's disease prediction algorithm based on hippocampal longitudinal hybrid morphological features

    Feng J, Ng KP, Wang H et al. · Quantitative imaging in medicine and surgery · 2026

  2. 0.92

    A regularized semiparametric cure-rate model with high-dimensional imaging data

    Feng J, Nanshan M, Shi H et al. · Statistical methods in medical research · 2026

  3. 0.92

    Utilizing multimodal models to forecast Alzheimer's disease progression and clinical subtypes

    Ren H, Jing F, Zhou Y et al. · Health information science and systems · 2026

  4. 0.91

    BrainAGE latent representation clustering is associated with longitudinal disease progression in early-onset Alzheimer's disease

    Manouvriez D, Kuchcinski G, Roca V et al. · Journal of neuroradiology = Journal de neuroradiologie · 2025

  5. 0.89

    Regional deep atrophy: Using temporal information to automatically identify regions associated with Alzheimer's disease progression from longitudinal MRI

    Dong M, Xie L, Das SR et al. · Imaging neuroscience (Cambridge, Mass.) · 2024

  6. 0.88

    A Machine Learning Pipeline for Prognostic Modeling of Alzheimer's Disease Using Multimodal Data

    De Palma L, D'Alessandro VI, Attivissimo F et al. · Sensors (Basel, Switzerland) · 2026

  7. 0.88

    Flexible Multimodal Neuroimaging Fusion for Alzheimer's Disease Progression Prediction

    Burns B, Xue Y, Scharre DW et al. · Applications of medical artificial intelligence. AMAI (Workshop) (4th : 2024 : Taejon-si, Korea) · 2026

  8. 0.88

    Data-driven spatiotemporal modeling reveals personalized trajectories of cortical atrophy in Alzheimer's disease

    Li C, Mao Y, Liu X et al. · ArXiv · 2025

  9. 0.88

    DYNAMIC PREDICTION WITH MULTIVARIATE LONGITUDINAL OUTCOMES AND LONGITUDINAL MAGNETIC RESONANCE IMAGING DATA

    Zou H, Xiao L, Zeng D et al. · The annals of applied statistics · 2025

  10. 0.87

    Temporal-multimodal consistency alignment for Alzheimer's cognitive assessment prediction

    Yang X, Dang X, Cai J et al. · Medical physics · 2025

  11. 0.87

    Deep learning to predict future cognitive decline: a multimodal approach using brain MRI and clinical data

    Chattopadhyay T, Senthilkumar P, Ankarath RH et al. · Frontiers in neuroimaging · 2026

  12. 0.87

    Morphogeometric variation analysis of cortical surfaces in Alzheimer's Disease. A novel approach for prognostic biomarker discovery

    Gonzalez-Cabrero J, Gomez C, Cavas F · Computer methods and programs in biomedicine · 2025

  13. 0.86

    Regional brain aging patterns reveal disease-specific pathways of neurodegeneration

    Vakli P, Weiss B, Keresztes A et al. · medRxiv : the preprint server for health sciences · 2025

  14. 0.86

    Disease progression modeling of Alzheimer's disease based on variational probability principal component analysis

    Xiong X, Wang X, Zhu C et al. · PloS one · 2026

  15. 0.86

    Multimodal Self-Supervised Learning for Early Alzheimer's: Cross-Modal MRI-PET, Longitudinal Signals, and Site Invariance

    Ali SB, Ghannam NE, Mancy H et al. · Diagnostics (Basel, Switzerland) · 2025

  16. 0.86

    Decoupling MCI-specific signatures from shared neurobiological substrates of cognitive aging via deep learning

    Peng B, Du L, Dang M et al. · NPJ digital medicine · 2026

  17. 0.85

    Multi-threshold polygenic risk improves hippocampal-based cognitive decline prediction

    Janahi M, Lorenzini L, Oxtoby NP et al. · Genome medicine · 2026

  18. 0.85

    A systematic study on the integration of MRI connectivity metrics for Alzheimer's diagnosis, staging, and cognitive decline prediction

    Ali S, Kreshpa W, Rosso N et al. · Frontiers in neuroimaging · 2026

  19. 0.85

    Mapping heterogeneous brain structural subtypes in alzheimer's disease and mild cognitive impairment using normative models

    Wei X, Zhang T, Xiong R et al. · Translational psychiatry · 2026

  20. 0.85

    CRAD: Cognitive Aware Feature Refinement with Missing Modalities for Early Alzheimer's Progression Prediction

    Liu F, Liang SN, Jaward MH et al. · Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society · 2025

  21. 0.85

    Hybrid multi-modality multi-task learning for forecasting progression trajectories in subjective cognitive decline

    Yu M, Fang Y, Liu Y et al. · Neural networks : the official journal of the International Neural Network Society · 2025

  22. 0.84

    A transformer-based unified multimodal framework for Alzheimer's disease assessment

    Yu Q, Ma Q, Da L et al. · Computers in biology and medicine · 2024

  23. 0.84

    Development and Validation of a Brain Aging Biomarker in Middle-Aged and Older Adults: Deep Learning Approach

    Li Z, Li J, Li J et al. · JMIR aging · 2025

  24. 0.83

    DunedinPACNI estimates the longitudinal Pace of Aging from a single brain image to track health and disease

    Whitman ET, Elliott ML, Knodt AR et al. · Nature aging · 2025

  25. 0.83

    Data-driven modeling of spatiotemporal dynamics using multimodal imaging data

    Li C, Mao Y, Liu X et al. · PLoS computational biology · 2026

  26. 0.83

    Deep multimodal learning for domain-level cognitive decline prediction in Alzheimer's disease

    Garcia-Gutierrez F, Matias-Guiu JA, Ayala JL · Frontiers in artificial intelligence · 2025

  27. 0.83

    SOM2LM: Self-Organized Multi-Modal Longitudinal Maps

    Ouyang J, Zhao Q, Adeli E et al. · Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention · 2024

  28. 0.82

    Analyzing heterogeneity in Alzheimer disease using multimodal normative modeling on imaging-based ATN biomarkers

    Kumar S, Earnest T, Yang B et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  29. 0.82

    Predicting categorical and continuous Alzheimer's disease outcomes from a single MRI scan

    Ma D, Pabalan C, Rajagopal A et al. · Nature aging · 2026

  30. 0.82

    Subtyping and staging of Alzheimer's disease from routine structural MRI with PHASE-AD

    Baumeister H, Lusebrink F, Kleineidam L et al. · medRxiv : the preprint server for health sciences · 2026

  31. 0.82

    Longitudinal dementia trajectories for Alzheimer's Disease characterization and prediction

    Mori Ad, Tauber C · Computers in biology and medicine · 2025

  32. 0.82

    Hybrid Multimodality Fusion with Cross-Domain Knowledge Transfer to Forecast Progression Trajectories in Cognitive Decline

    Yu M, Liu Y, Wu J et al. · Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention · 2023

  33. 0.81

    An estimate of the longitudinal pace of aging from a single brain scan predicts dementia conversion, morbidity, and mortality

    Whitman ET, Elliott ML, Knodt AR et al. · bioRxiv : the preprint server for biology · 2025

  34. 0.80

    Discovering Heterogeneous Neurodegenerative Disease Patterns From MRI Data for Improved Prediction

    Zhang Y, Li H, Fan Y · Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention · 2027

  35. 0.80

    A novel deep learning-based brain age prediction framework for routine clinical MRI scans

    Kim H, Park S, Seo SW et al. · npj aging · 2025

  36. 0.79

    PatientSpace: A multimodal graph-based latent representation framework for modeling neurodegenerative disease heterogeneity

    Manouvriez D, Kuchcinski G, Lecerf S et al. · NeuroImage · 2026

  37. 0.79

    Constructing personalized characterizations of structural brain aberrations in patients with dementia using explainable artificial intelligence

    Leonardsen EH, Persson K, Grodem E et al. · NPJ digital medicine · 2024

  38. 0.79

    An explainable AI approach for mapping multivariate regional brain age and clinical severity patterns in Alzheimer's disease

    Darekar G, Murad T, Miao HY et al. · Biology methods & protocols · 2025

  39. 0.79

    NeuroOmics-Net: An interpretable multimodal deep learning framework for Alzheimer's disease diagnosis and progression prediction using neuroimaging, EEG, and genomic data

    Kavitha R, Premalatha K · Computers in biology and medicine · 2026

  40. 0.78

    Exploring Brain Imaging and Genetic Risk Factors in Different Progression States of Alzheimer's Disease Through OSnetNMF-Based Methods

    Gao M, Kong W, Liu K et al. · Journal of molecular neuroscience : MN · 2025

  41. 0.77

    Resolving Heterogeneity in the Diagnosis of Alzheimer's Disease and its Progression Using Multimodal Data

    Hu F, Tang NLS, Wang H et al. · Journal of molecular neuroscience : MN · 2026

  42. 0.77

    Deep normative modelling reveals insights into early-stage Alzheimer's disease using multi-modal neuroimaging data

    Lawry Aguila A, Lorenzini L, Janahi M et al. · Alzheimer's research & therapy · 2025

  43. 0.77

    Deep Geometric Learning With Monotonicity Constraints for Alzheimer's Disease Progression

    Jeong S, Jung W, Sohn J et al. · IEEE transactions on neural networks and learning systems · 2025

  44. 0.76

    Deep learning models identify brain changes during the progression of Alzheimer's disease

    Sun J, Han JDJ, Chen W · NPJ systems biology and applications · 2026

  45. 0.76

    Enhancing brain age estimation with structural MRI and synthesized cerebral blood volume maps

    Jomsky J, Li Z, Igwe KC et al. · Brain communications · 2026

  46. 0.76

    Structural similarity networks reveal brain vulnerability in dementia

    Montagnese M, Ebneabbasi A, Garcia-San-Martin N et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  47. 0.76

    AgeNet-SHAP: An explainable AI approach for optimally mapping multivariate regional brain age and clinical severity patterns in Alzheimer's disease

    Darekar G, Murad T, Miao HY et al. · medRxiv : the preprint server for health sciences · 2025

  48. 0.75

    A Latent-Class Model for Time-To-Event Outcomes and High-Dimensional Imaging Data

    Feng J, Shi H, Da M et al. · Statistics in medicine · 2025

  49. 0.75

    Unsupervised Disentanglement of Brain Heterogeneity for Identifying Subtypes of Alzheimer's Disease

    Zhang H, Wang D, Yang J et al. · IEEE transactions on bio-medical engineering · 2026

  50. 0.75

    Brain age identification from diffusion MRI synergistically predicts neurodegenerative disease

    Gao C, Kim ME, Ramadass K et al. · Imaging neuroscience (Cambridge, Mass.) · 2025

  51. 0.75

    An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease

    Dolci G, Cruciani F, Abdur Rahaman M et al. · Journal of neural engineering · 2025

  52. 0.75

    Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach

    Dai Y, Hsu YC, Fernandes BS et al. · Journal of Alzheimer's disease : JAD · 2024

  53. 0.75

    Geometric brain signatures of Alzheimer's disease progression and subtypes

    Tong B, Cao T, Duong-Tran D et al. · medRxiv : the preprint server for health sciences · 2026

  54. 0.74

    Unsupervised Sparse Multi-Task Learning With Application to Alzheimer's Disease

    Chen H, Ji J, Liu D et al. · Statistics in medicine · 2026

  55. 0.73

    Analyzing heterogeneity in Alzheimer Disease using multimodal normative modeling on imaging-based ATN biomarkers

    Kumar S, Earnest T, Yang B et al. · ArXiv · 2024

  56. 0.73

    Unsupervised multimodal modeling of cognitive and brain health trajectories for early dementia prediction

    Burkhart MC, Lee LY, Vaghari D et al. · Scientific reports · 2024

  57. 0.73

    Multimodal subtypes identified in Alzheimer's Disease Neuroimaging Initiative participants by missing-data-enabled subtype and stage inference

    Estarellas M, Oxtoby NP, Schott JM et al. · Brain communications · 2024

  58. 0.73

    Adaptive Integration of Incomplete Multimodal 3D Neuroimaging for Alzheimer's Prediction and Biomarker Discovery

    Ballard JL, Shen L, Long Q · AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026

  59. 0.72

    Staging and Pseudotime Inference of Alzheimer's Disease Progression using Multimodal Imaging Data

    Nair AA, Wen Z, Wang Z et al. · Proceedings. IEEE International Conference on Healthcare Informatics · 2026

  60. 0.72

    A Two-Stage Framework for Early Detection and Subtype Identification of Alzheimer's Disease Through Multimodal Biomarker Extraction and Improved GCN

    Li J, Kong W, Wang S · Brain sciences · 2026

  61. 0.70

    From voxel discovery to regional interaction: A multi-level interpretable framework for Alzheimer's disease diagnosis

    Shu K, Li J, Zhang R et al. · Medical image analysis · 2026

  62. 0.68

    Forecasting Future Anatomies: Longitudinal Brain Mri-to-Mri Prediction

    Farki A, Moradi E, Koundal D et al. · ArXiv · 2025

  63. 0.68

    Brain age gap as a predictive biomarker that links aging, lifestyle, and neuropsychiatric health

    Zhang R, Yi F, Mao H et al. · Communications medicine · 2025

  64. 0.67

    Evaluating Homoscedastic Uncertainty Weighting and Generative Tau Imputation in a Multimodal, Multitask Deep Learning Framework for Alzheimer's Disease

    Caposova R, Blackwell T · Neuroinformatics · 2026

  65. 0.65

    Latent Space Projections and Atlases, a Cautionary Tale in Deep Neuroimaging using Autoencoders

    Gorriz JM, Segovia F, Jimenez-Mesa C et al. · International journal of neural systems · 2026

  66. 0.64

    Brain Latent Progression: Individual-based spatiotemporal disease progression on 3D Brain MRIs via latent diffusion

    Puglisi L, Alexander DC, Ravi D · Medical image analysis · 2025

  67. 0.63

    Structural Brain Differences in the Alzheimer's Disease Continuum: Insights Into the Heterogeneity From a Large Multisite Neuroimaging Consortium

    Evans TE, Vilor-Tejedor N, Operto G et al. · Biological psychiatry. Cognitive neuroscience and neuroimaging · 2025

  68. 0.62

    Alzheimer's Disease Brain Phenotypes are Age-dependent

    Travi F, Mehta A, Castro E et al. · bioRxiv : the preprint server for biology · 2026

  69. 0.62

    AD-DAE: Alzheimer's Disease Progression Modeling with Unpaired Longitudinal MRI using Diffusion Auto-Encoders

    Das A, Sarkar A, Ram K et al. · IEEE journal of biomedical and health informatics · 2026

  70. 0.62

    Thalamic nuclei segmentation from T1-weighted MRI: Unifying and benchmarking state-of-the-art methods

    Williams B, Nguyen D, Vidal JP et al. · Imaging neuroscience (Cambridge, Mass.) · 2024

  71. 0.62

    Explainable AI for MRI Alzheimer's disease classification: A comparative analysis

    Persson S, Svenberg H, Rial AM et al. · NeuroImage · 2026

  72. 0.62

    OpenMAP-BrainAge: generalizable and interpretable brain age predictor from MRI

    Kan P, Jones C, Oishi K · Radiology advances · 2026

  73. 0.60

    Unveiling Alzheimer's disease through brain age estimation using multi-kernel regression network and magnetic resonance imaging

    Pilli R, Goel T, Murugan R · Computer methods and programs in biomedicine · 2025

  74. 0.59

    Resting-state fMRI foundation models enable robust and generalizable latent neural target discovery in cognitive aging interventions

    Zhou X, Ai M, Adeli E et al. · bioRxiv : the preprint server for biology · 2026

  75. 0.59

    Inspired by pathogenic mechanisms: A novel gradual multi-modal fusion framework for mild cognitive impairment diagnosis

    Tian X, Li HD, Lin H et al. · Neural networks : the official journal of the International Neural Network Society · 2025

  76. 0.58

    What Do Persistent Misclassifications Tell Us About Alzheimer's Disease Detection using Structural MRI?

    Stark D, Shin H, Munster N et al. · medRxiv : the preprint server for health sciences · 2026

  77. 0.57

    Brain age prediction via cross-stratified ensemble learning

    Li X, Hao Z, Li D et al. · NeuroImage · 2024

  78. 0.57

    Enhancing Brain Age Prediction and Neurodegeneration Detection with Contrastive Learning on Regional Biomechanical Properties

    Trauble J, Hiscox LV, Johnson C et al. · bioRxiv : the preprint server for biology · 2025

  79. 0.57

    Exploring the relationship among Alzheimer's disease, aging and cognitive scores through neuroimaging-based approach

    Sun J, Han JDJ, Chen W · Scientific reports · 2024

  80. 0.57

    Geodesic shape regression based deep learning segmentation for assessing longitudinal hippocampal atrophy in dementia progression

    Gao N, Chen H, Guo X et al. · NeuroImage. Clinical · 2024

  81. 0.56

    Adapting Machine Learning Diagnostic Models to New Populations Using a Small Amount of Data: Results from Clinical Neuroscience

    Wang R, Erus G, Chaudhari P et al. · ArXiv · 2024

  82. 0.56

    Forecasting individualized progression of Alzheimer's disease using structural MRI and population spatiotemporal priors

    Zhao Y, Che T, Wang X et al. · Frontiers in aging neuroscience · 2026

  83. 0.55

    CE-GAN: Community Evolutionary Generative Adversarial Network for Alzheimer's Disease Risk Prediction

    Bi XA, Yang Z, Huang Y et al. · IEEE transactions on medical imaging · 2024

  84. 0.55

    A vision-language foundation model for Alzheimer's disease diagnosis using MRI and clinical data

    Lin PJ, Jiang Z, Liu Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  85. 0.55

    Multivariate Random Forests for Cross-Modal Multi-Omics Integration

    Zhang W, Wang L, Franzmann EJ et al. · bioRxiv : the preprint server for biology · 2026

  86. 0.54

    Disentangled Representation Learning for Capturing Individualized Brain Atrophy via Pseudo-Healthy Synthesis

    Li Z, Zhao K, Chen P et al. · IEEE journal of biomedical and health informatics · 2025

  87. 0.53

    Generative diffusion model enables quantification of calibration-free arterial spin labeling perfusion magnetic resonance imaging data in an Alzheimer's disease cohort

    Shou Q, Cen S, Chen NK et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2025

  88. 0.51

    Exploring Imaging Genetic Markers of Alzheimer's Disease Based on a Novel Nonlinear Correlation Analysis Algorithm

    Yang R, Kong W, Liu K et al. · Journal of molecular neuroscience : MN · 2024

  89. 0.51

    Regional patch-based MRI brain age modeling with an interpretable cognitive reserve proxy

    Maddox S, Puglisi L, Darabifard F et al. · Pattern recognition letters · 2026

  90. 0.51

    BrainAGE: Revisited and reframed machine learning workflow

    Kalc P, Dahnke R, Hoffstaedter F et al. · Human brain mapping · 2024

  91. 0.51

    Unravelling pathological ageing with brain age gap estimation in Alzheimer's disease, diabetes and schizophrenia

    Dias MF, Duarte JV, de Carvalho P et al. · Brain communications · 2025

05functional · connectivity87편

  1. 0.92

    Differences of individual gray matter networks between MCI patients who converted to AD within 3 Years and nonconverters

    Zhou B, Zhao Y, Wu X · Heliyon · 2024

  2. 0.92

    Increased between-network connectivity: A risk factor for tau elevation and disease progression

    Hojjati SH, Butler TA, Luchsinger JA et al. · Neuroscience letters · 2024

  3. 0.91

    Default mode network failure across the Alzheimer's disease spectrum

    Corriveau-Lecavalier N, Dicks E, Martin PR et al. · Brain : a journal of neurology · 2026

  4. 0.91

    Functional connectome metrics reveal distinct prognostic subtypes in two Phase 3 gantenerumab trials

    Gobbi S, Silvestri E, Tonietto M et al. · Alzheimer's & dementia (New York, N. Y.) · 2026

  5. 0.90

    Anterior-temporal network hyperconnectivity is key to Alzheimer's disease: from ageing to dementia

    Chauveau L, Landeau B, Dautricourt S et al. · Brain : a journal of neurology · 2025

  6. 0.89

    Connectome-based prediction of future episodic memory performance for individual amnestic mild cognitive impairment patients

    Zhang Z, Wang M, Lu T et al. · Brain communications · 2025

  7. 0.89

    Functional system-specific brain aging across the Alzheimer's disease continuum

    Huo Y, Huang W, Liu Z et al. · Translational psychiatry · 2026

  8. 0.88

    Regional-based static and dynamic alterations in Alzheimer disease: a longitudinal study

    Usha KC, Suma HN, Appaji A · Arquivos de neuro-psiquiatria · 2024

  9. 0.87

    A novel spatiotemporal graph convolutional network framework for functional connectivity biomarkers identification of Alzheimer's disease

    Zhang Y, Xue L, Zhang S et al. · Alzheimer's research & therapy · 2024

  10. 0.87

    Classification of mild cognitive impairment developmental trajectories using multispatial scale structural brain networks

    Zhang C, Song C, Li X et al. · Neuroreport · 2025

  11. 0.86

    Graph-based deep learning models in the prediction of early-stage Alzheimers

    Thapaliya B, Wu Z, Sapkota R et al. · Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2024

  12. 0.86

    A longitudinal study of functional brain complexity in progressive Alzheimer's disease

    Zhang R, Aksman L, Wijesinghe D et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2025

  13. 0.85

    Directed Functional Connectivity Changes of Triple Networks for Stable and Progressive Mild Cognitive Impairment

    Zheng D, Ruan Y, Cao X et al. · Neuroscience · 2024

  14. 0.85

    Reorganized brain functional network topology in stable and progressive mild cognitive impairment

    Xue C, Zheng D, Ruan Y et al. · Frontiers in aging neuroscience · 2024

  15. 0.84

    Decoupling of local activity and interhemispheric connectivity in late mild cognitive impairment: A resting-state functional magnetic resonance imaging study

    Jin Z · Neuropsychology · 2026

  16. 0.84

    Connectome-based predictive modeling of brain pathology and cognition in Autosomal Dominant Alzheimer's Disease

    Tripathi V, Fox-Fuller J, Malotaux V et al. · medRxiv : the preprint server for health sciences · 2024

  17. 0.84

    Progression from mild cognitive impairment to dementia in Alzheimer's disease: Whole cortex voxelwise functional connectivity analysis with multivariate distance matrix regression

    Ferreira LK, Westman E, Wahlund LO et al. · Journal of Alzheimer's disease : JAD · 2026

  18. 0.83

    Elevated functional magnetic resonance imaging activity in cognitively normal participants predicts future dementia

    Clemens SG, Hobbs DA, McKay NS et al. · Brain communications · 2026

  19. 0.83

    Functional connectivity density as a biomarker for Alzheimer's disease: Distinct neural mechanisms in young- and late-onset subtypes

    Chang HI, Hsu SW, Huang SH et al. · Psychiatry and clinical neurosciences · 2026

  20. 0.83

    Shannon Entropy of Gray Matter Eigenmodes: A Novel Biomarker for Alzheimer's Disease and Heterogeneous MCI Trajectories

    Li Y, Long G, Zhang X et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026

  21. 0.83

    Dynamic Synergy Network Analysis Reveals Stage-Specific Regional Dysfunction in Alzheimer's Disease

    Zhang X, Han C, Xia J et al. · Brain sciences · 2025

  22. 0.83

    Longitudinal trajectories of amyloid-beta-driven alterations in voxel-mirrored homotopic connectivity and cognitive decline in mild cognitive impairment

    Chi L, Qiao M, Huang A et al. · Journal of Alzheimer's disease : JAD · 2026

  23. 0.82

    Sex differences in functional connectivity and the predictive role of the connectome-based predictive model in Alzheimer's disease

    Li Y, Zhu W, Zhou S et al. · Journal of neuroscience research · 2024

  24. 0.82

    Hippocampal-cortical structural networks in the progression of cognitive impairment: A source-based morphometry analysis in individuals with subjective cognitive decline, mild cognitive impairment and Alzheimer's disease

    Serra L, Mancini M, Bonarota S et al. · Neurobiology of aging · 2026

  25. 0.82

    Alteration of functional connectivity network in population of objectively-defined subtle cognitive decline

    Zhang X, Zeng Q, Wang Y et al. · Brain communications · 2024

  26. 0.81

    Early detection of dementia with default-mode network effective connectivity

    Ereira S, Waters S, Razi A et al. · Nature. Mental health · 2024

  27. 0.81

    Multimodal Imaging of Tau Pathology and Network Connectivity Dynamics Across the Alzheimer's Continuum: A Pilot Study Using Second-Generation Tracer [(18)F]MK6240

    Piao S, Wang J, He K et al. · Academic radiology · 2026

  28. 0.81

    Specificity of functional network connectivity during the AD prodromal phase in mild cognitive impairment

    Li W, Feng Z, Chu B et al. · Frontiers in psychiatry · 2025

  29. 0.80

    Altered Hierarchical Gradients of Intrinsic Neural Timescales in Mild Cognitive Impairment and Alzheimer's Disease

    Zhang A, Wengler K, Zhu X et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024

  30. 0.80

    Delineating the Heterogeneity of Alzheimer's Disease and Mild Cognitive Impairment Using Normative Models of Dynamic Brain Functional Networks

    Huo Y, Jing R, Li P et al. · Biological psychiatry · 2025

  31. 0.80

    Functional network phenotypes of mild behavioural impairment: cognitive effects moderated by amyloid

    Ng KP, Chong JSX, Lussier F et al. · Alzheimer's research & therapy · 2026

  32. 0.78

    A deep spatio-temporal attention model of dynamic functional network connectivity shows sensitivity to Alzheimer's in asymptomatic individuals

    Wei Y, Abrol A, Lah J et al. · Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2024

  33. 0.77

    Hyperbolic embedding of brain networks detects regions disrupted by neurodegeneration in Alzheimer's disease

    Longhena A, Guillemaud M, Fallani FDV et al. · Physical review. E · 2025

  34. 0.77

    Prediction of Cognitive Progression Due to Alzheimer's Disease in Normal Participants Based on Individual Default Mode Network Metabolic Connectivity Strength

    Zhang Q, Li F, Wei M et al. · Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024

  35. 0.76

    Whole-Brain Static Functional Connectivity Disruptions Based on the Default Mode Network in Patients with Mild Cognitive Impairment

    Zeng Y, Shao Y, Zhou D et al. · Brain topography · 2026

  36. 0.76

    Altered resting-state functional connectivity in individuals at risk for Alzheimer's disease: a longitudinal study

    Chavarria-Elizondo P, Maturana-Quijada P, Martinez-Zalacain I et al. · International journal of clinical and health psychology : IJCHP · 2025

  37. 0.76

    Altered intrinsic ignition dynamics linked to Amyloid-beta and tau pathology in Alzheimer's disease

    Patow GA, Escrichs A, Martinez-Molina N et al. · bioRxiv : the preprint server for biology · 2025

  38. 0.76

    Differences in patterns of functional and structural connectivity alterations of hippocampal subregions in patients on the Alzheimer's disease spectrum

    Ni L, Lin L, Zhao W et al. · Neuroscience · 2025

  39. 0.75

    Alzheimer's disease pathogenesis and the role of APOE epsilon4 in remodeling functional gradients of the default mode network

    Song W, Gong C, Li Y et al. · Journal of Alzheimer's disease : JAD · 2025

  40. 0.75

    Early functional disconnection of the basal forebrain-hippocampal system predicts memory impairment in amnestic mild cognitive impairment

    Lu JJ, Xu ZJ, Ma J et al. · Neuroscience · 2026

  41. 0.74

    Analysis of the difference between Alzheimer's disease, mild cognitive impairment and normal people by using fractal dimensions and small-world network

    Lee WK, Hinrichs C, Chen YL et al. · Progress in brain research · 2024

  42. 0.73

    Connectome-based predictive modeling of brain pathology and cognition in autosomal dominant Alzheimer's disease

    Tripathi V, Fox-Fuller J, Malotaux V et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  43. 0.73

    Characterizing structure-function coupling in subjective memory complaints of preclinical Alzheimer's disease

    Wei C, Wang J, Xue Y et al. · Journal of Alzheimer's disease : JAD · 2025

  44. 0.72

    3D convolutional neural networks uncover modality-specific brain-imaging predictors for Alzheimer's disease sub-scores

    Ning K, Cannon PB, Yu J et al. · Brain informatics · 2024

  45. 0.72

    Structure-function coupling using fixel-based analysis and functional magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment

    Billaud CHA, Yu J · Network neuroscience (Cambridge, Mass.) · 2025

  46. 0.72

    Exploring the impact of APOE varepsilon4 on functional connectivity in Alzheimer's disease across cognitive impairment levels

    Dong K, Liang W, Hou T et al. · NeuroImage · 2025

  47. 0.70

    Aberrant functional connectivity between the retrosplenial cortex and hippocampal subregions in amnestic mild cognitive impairment and Alzheimer's disease

    Wang J, Liu S, Liang P et al. · Brain communications · 2025

  48. 0.70

    Brain functional specialization and cooperation in Alzheimer's disease

    Wu Y, Gao M, Lv L et al. · Brain and behavior · 2024

  49. 0.69

    Characteristic indicators for mild-cognitive-impairment obtained from dimension reduction of brain networks

    Weng X, Xu M, Wu Z · Psychiatry research. Neuroimaging · 2025

  50. 0.68

    Sex-Specific Entorhinal Cortex Functional Connectivity in Cognitively Normal Older Adults with Amyloid-beta Pathology

    Gong L, Liu D, Zhang B et al. · Molecular neurobiology · 2025

  51. 0.67

    Alterations of resting-state network dynamics in Alzheimer's disease based on leading eigenvector dynamics analysis

    Yang YL, Liu YX, Wei J et al. · Journal of neurophysiology · 2024

  52. 0.67

    Impaired olfactory identification in dementia-free individuals is associated with the functional abnormality of the precuneus

    Xie B, Yang S, Hao Y et al. · Neurobiology of disease · 2024

  53. 0.66

    Smoking alters effective connectivity of resting-state brain networks in mild cognitive impairment

    Zhang T, Luo X, Zeng Q et al. · Journal of Alzheimer's disease : JAD · 2025

  54. 0.65

    APOE genotype modulates the impact of sleep duration on locus coeruleus functional connectivity in pre-clinical Alzheimer's disease

    Gong L, Li H, Li M et al. · Brain communications · 2025

  55. 0.65

    Non-linear associations of amyloid-beta with resting-state functional networks and their cognitive relevance in a large community-based cohort of cognitively normal older adults

    Wu J, Risk BB, James TA et al. · ArXiv · 2025

  56. 0.64

    Classification of Mild Cognitive Impairment Based on Dynamic Functional Connectivity Using Spatio-Temporal Transformer

    Zhang J, Lyu Y, Yu X et al. · ArXiv · 2025

  57. 0.63

    Lost in space(s): Multimodal neuroimaging of disorientation along the Alzheimer's disease continuum

    Peters-Founshtein G, Gazit L, Naveh T et al. · Human brain mapping · 2024

  58. 0.63

    Resting-State Cerebral Blood Flow and Its Disconnect From Functional Connectivity in Alzheimer's Disease Spectrum

    Su X, Wang Y, Zhao B et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2026

  59. 0.62

    The alterations in brain network functional gradients and dynamic functional connectivity in Alzheimer's disease: a resting-state fMRI study

    Liu B, Chen C, Cai P et al. · Frontiers in aging neuroscience · 2025

  60. 0.61

    Decreased amyloid-related structure-function coupling in preclinical Alzheimer's disease

    Arunachalam P, Pieperhoff L, Lorenzini L et al. · Communications medicine · 2026

  61. 0.61

    Predicting the efficacy of donepezil intervention in Alzheimer's disease patients using regional homogeneity in the inferior orbitofrontal cortex

    Dai M, Guo Z, Xia H et al. · Aging clinical and experimental research · 2024

  62. 0.60

    CLASSIFFICATION OF MILD COGNITIVE IMPAIRMENT BASED ON DYNAMIC FUNCTIONAL CONNECTIVITY USING SPATIO-TEMPORAL TRANSFORMER

    Zhang J, Lyu Y, Yu X et al. · Proceedings. IEEE International Symposium on Biomedical Imaging · 2025

  63. 0.60

    Causal relationships between alzheimer's disease genetics and brain connectivity alterations: a multi-modal mendelian randomization study with transcriptomic validation of 191 rs-fMRI and 635 DTI neuroimaging traits

    Ji J, Li Z, Xing A et al. · Brain imaging and behavior · 2026

  64. 0.60

    Moderating role of executive function in the relationship between specific white matter changes and long-term delayed recall in aMCI patients

    Li LL, Ma J, Wu JJ et al. · Alzheimer's research & therapy · 2026

  65. 0.60

    Diffusion MRI reveals amyloid plaque-associated cellular signatures through spatial transcriptomic integration

    Han X, Hu R, Ping X et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  66. 0.59

    Alterations in topological and dynamical parameters correlate with disease biomarkers and neuropsychological scores in prodromic stages of dementia

    Monteverdi A, Cotta Ramusino M, Conca F et al. · Scientific reports · 2026

  67. 0.59

    A whole-brain functional connectivity model of Alzheimer's disease pathology

    Prakash RS, McKenna MR, Gbadeyan O et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  68. 0.59

    Exploring the interaction of APOE-epsilon4and PICALM rs3851179 with dynamic functional connectivity in healthy middle-aged adults at risk for Alzheimer's disease

    Dharia SY, Valderrama CE, Liu Q et al. · Journal of neural engineering · 2026

  69. 0.59

    Atypical cortical hierarchy in Abeta-positive older adults and its reflection in spontaneous speech

    He R, Al-Tamimi J, Sanchez-Benavides G et al. · Brain research · 2024

  70. 0.58

    Amyloid-related default mode network hyperconnectivity and longitudinal decline in network distinctiveness in preclinical Alzheimer's disease

    Cha WJ, Chumin EJ, Yi D et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  71. 0.58

    Detection of structural-functional coupling abnormalities using multimodal brain networks in Alzheimer's disease: A comparison of three computational models

    Lu Y, Wang L, Murai T et al. · NeuroImage. Clinical · 2025

  72. 0.58

    Multi-modal Neuroimaging Phenotyping of Mnemonic Anosognosia in the Aging Brain

    Bueicheku E, Diez I, Gagliardi G et al. · Communications medicine · 2024

  73. 0.58

    Co-Community Network Analysis Reveals Alterations in Brain Networks in Alzheimer's Disease

    Wang X, Zhang Z, Deng L et al. · Brain sciences · 2025

  74. 0.57

    A mediation approach in resting-state connectivity between the medial prefrontal cortex and anterior cingulate in mild cognitive impairment

    Huang YT, Yan SH, Chuang YF et al. · Aging clinical and experimental research · 2024

  75. 0.57

    Dementia Subtypes Defined Through Neuropsychiatric Symptom-Associated Brain Connectivity Patterns

    Zhao K, Xie H, Fonzo GA et al. · JAMA network open · 2024

  76. 0.57

    Functional connectivity patterns of the cerebellar components of intrinsic connectivity networks in clinically diagnosed probable Alzheimer's disease

    Hari E, Ulasoglu-Yildiz C, Kurt E et al. · BMC medical imaging · 2026

  77. 0.56

    Neural network disruptions between default mode network and salience network in mild cognitive impairment with neuropsychiatric symptoms

    Pan C, Li R, Yuan X et al. · International psychogeriatrics · 2025

  78. 0.56

    Revealing excitation-inhibition imbalance in Alzheimer's disease using multiscale neural model inversion of resting-state functional MRI

    Li G, Hsu LM, Wu Y et al. · Communications medicine · 2025

  79. 0.55

    Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease

    de Bruin H, Groot C, Barthel H et al. · Brain : a journal of neurology · 2025

  80. 0.55

    Functional network contributions to longitudinal tau spread in Posterior Cortical Atrophy

    Katsumi Y, Eckbo R, McGinnis SM et al. · NPJ dementia · 2026

  81. 0.55

    Amyloid pathology related to aberrant structure-function coupling of brain networks in Alzheimer's disease: insights from [(18)F]-florbetapir PET imaging

    Chen HJ, Zhang M, Wei M et al. · European journal of nuclear medicine and molecular imaging · 2025

  82. 0.54

    Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, double-blind, placebo-controlled trial

    Han X, Gong S, Gong J et al. · Psychiatry and clinical neurosciences · 2025

  83. 0.52

    Cognitive reserve linked to network-specific brain-ventricle coupling modes

    Campo FF, Brattico E, Miguel V et al. · bioRxiv : the preprint server for biology · 2025

  84. 0.51

    The association between individualized functional connectivity disruption and metabolic abnormality in alzheimer's disease and mild cognitive impairment: insights from multimodal neuroimaging

    Gao Y, Lin S, Jiang M et al. · Neuroradiology · 2026

  85. 0.51

    Longitudinal alterations in morphometric inverse divergence networks among diabetes patients with progressive cognitive decline

    Bao YW, Zhou Y, Wei DF et al. · Brain research bulletin · 2026

  86. 0.51

    Resting-state functional dynamics alterations relate to plasma amyloid markers and statistically explain memory impairments in the TgF344-AD model of Alzheimer's disease

    Al-Awlaqi A, Berckmans L, De Waegenaere S et al. · Alzheimer's research & therapy · 2026

  87. 0.50

    Lower Network Functional Connectivity Is Associated With Higher Regional Tau Burden Among Those At-Risk of Alzheimer's Disease But Cognitively Unimpaired: Specific Patterns Based on Amyloid Status

    Ford J, Mohanty R, Westman E et al. · Research square · 2025

06accuracy · classification74편

  1. 0.93

    Predicting conversion from mild cognitive impairment to Alzheimer's disease using a Vision Transformer and hippocampal MRI slices

    Seiger R, Fierlinger P · medRxiv : the preprint server for health sciences · 2025

  2. 0.92

    Predicting the Conversion From Mild Cognitive Impairment to Alzheimer's Disease Using Graph Frequency Bands and Functional Connectivity-based Features

    Zamani J, Talesh Jafadideh A · Basic and clinical neuroscience · 2025

  3. 0.91

    Detecting Mild Cognitive Impairment to Alzheimer's Disease Progression by fMRI Using Convolutional Neural Network and Long-short Term Memory

    Ghafoori S, Shalbaf A · Basic and clinical neuroscience · 2025

  4. 0.91

    Leveraging hemispheric asymmetry in structural MRI with an attention-guided 3D CNN for early prediction of Alzheimer's conversion

    Liu Y, Yao L, Liu J et al. · Neural networks : the official journal of the International Neural Network Society · 2026

  5. 0.90

    Early detection of Alzheimer's disease progression: comparative evaluation of deep learning models

    Shetty J, Shenoy MK, Kolekar SV et al. · Scientific reports · 2025

  6. 0.90

    Attention-Guided 3D CNN With Lesion Feature Selection for Early Alzheimer's Disease Prediction Using Longitudinal sMRI

    Liu J, Xu Y, Liu Y et al. · IEEE journal of biomedical and health informatics · 2025

  7. 0.89

    Predicting the Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Graph Frequency Bands and Functional Connectivity-Based Features

    Zamani J, Jafadideh AT · Research square · 2024

  8. 0.89

    Longitudinal Feature Disentanglement With Cross-Time Contrastive Learning for Alzheimer's Disease Diagnosis

    Dai D, Zhang N, Zhang H et al. · IEEE journal of biomedical and health informatics · 2026

  9. 0.89

    A token efficient vision framework using patch residual transformer for Alzheimer's disease diagnosis

    Huang F, Zhu P, Chen N et al. · Scientific reports · 2026

  10. 0.89

    An integrated predictive model for Alzheimer's disease progression from cognitively normal subjects using generated MRI and interpretable AI

    Aghaei A, Moghaddam ME · Scientific reports · 2025

  11. 0.87

    Dual attention based fusion network for MCI Conversion Prediction

    Luo M, He Z, Cui H et al. · Computers in biology and medicine · 2024

  12. 0.86

    Applying ensemble machine learning techniques to MRI scans to predict Alzheimer's disease

    Theocharidis G, Bisdas S, Pazarzis J et al. · Scientific reports · 2026

  13. 0.85

    Latent diffusion model-based MRI superresolution enhances mild cognitive impairment prognostication and Alzheimer's disease classification

    Yoon D, Myong Y, Kim YG et al. · NeuroImage · 2024

  14. 0.85

    A lightweight triple-modal fusion network for progressive mild cognitive impairment prediction in Alzheimer's disease

    Shen X, Hu X, Zhang R et al. · Frontiers in neuroscience · 2025

  15. 0.84

    An interpretable machine learning framework with data-informed imaging biomarkers for diagnosis and prediction of Alzheimer's disease

    Kang W, Li B, Jiskoot LC et al. · Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society · 2026

  16. 0.82

    Adversarial Learning for MRI Reconstruction and Classification of Cognitively Impaired Individuals

    Zhou X, Balachandra AR, Romano MF et al. · IEEE access : practical innovations, open solutions · 2024

  17. 0.80

    Brain Region-Centered MultiModal Hypergraph Fusion for MCI Conversion Prediction

    Dong Z, Liu H, Ge X et al. · IEEE journal of biomedical and health informatics · 2026

  18. 0.80

    Updated Models of Alzheimer's Disease with Deep Neural Networks

    Sakharova T, Mao S, Osadchuk M · Journal of Alzheimer's disease : JAD · 2024

  19. 0.80

    Efficient Slice-Patch Selection Transformer for Interpretable Alzheimer's Disease Diagnosis Using Structural MRI

    Cao G, Zhang M, Wang Y et al. · IEEE journal of biomedical and health informatics · 2026

  20. 0.79

    Longitudinal MRI analysis using a hybrid DenseNet-BiLSTM method for Alzheimer's disease prediction

    Jomeiri A, Navin AH, Shamsi M · Behavioural brain research · 2024

  21. 0.78

    Generative Adversarial Networks Based on Fine-Grained Image Recognition for the Progression Prediction of Progressive Mild Cognitive Impairment

    Shen C, Wu F, Liao B et al. · Interdisciplinary sciences, computational life sciences · 2026

  22. 0.77

    SMaRT-Net: A novel framework of 7T brain MRI superresolution for Alzheimer's disease diagnosis and mild cognitive impairment prognostication

    Yoon D, Myong Y, Kim YG et al. · NeuroImage · 2026

  23. 0.76

    MTC-MSFFNet: a multi-task classification model based on multi-source feature fusion for Alzheimer's disease

    Gao J · Biomedical physics & engineering express · 2026

  24. 0.76

    A longitudinal and explainable 2.5D deep learning framework for Alzheimer's disease progression using ADNI MRI

    Soelistiono S · Neuroimage. Reports · 2026

  25. 0.76

    Metaheuristic-driven dual-layer model for classifying Alzheimer's disease stages

    Anicin L, Andjelic S, Markovic Blagojevic M et al. · Frontiers in computational neuroscience · 2026

  26. 0.75

    Novel multi-task learning for Alzheimer's stage classification using hippocampal MRI segmentation, feature fusion, and nomogram modeling

    Hu W, Du Q, Wei L et al. · European journal of medical research · 2025

  27. 0.74

    TASNet: A tri-modal attentive scale robust adaptive fusion framework for progressive mild cognitive impairment classification

    Zhu H, Zhang L, Yang L et al. · Journal of neuroscience methods · 2026

  28. 0.73

    Classification method based on surf and sift features for alzheimer diagnosis using diffusion tensor magnetic resonance imaging

    Zayed N, Eldeep G, Yassine IA · Scientific reports · 2025

  29. 0.73

    Transformer attention-based neural network for cognitive score estimation from sMRI data

    Li S, Zhang Y, Zou C et al. · Computers in biology and medicine · 2025

  30. 0.72

    A multispatial information representation model emphasizing key brain regions for Alzheimer's disease diagnosis with structural magnetic resonance imaging

    Nan P, Li L, Song Z et al. · Quantitative imaging in medicine and surgery · 2024

  31. 0.71

    Heterophily-Aware Spectral GCN for Population-Level Brain Disorder Prediction

    Zhang H, Wang L, Zhao Y et al. · IEEE journal of biomedical and health informatics · 2026

  32. 0.70

    X-ViTCNN: A Novel Network-Level Fusion of Transfer Learning and Customized Vision Transformer for Multi-Stage Alzheimer's Disease Prediction Using MRI Scans

    Ali A, Shahbaz H, Ganie SM et al. · Diagnostics (Basel, Switzerland) · 2026

  33. 0.70

    An imaging and genetic-based deep learning network for Alzheimer's disease diagnosis

    Li Y, Niu D, Qi K et al. · Frontiers in aging neuroscience · 2025

  34. 0.68

    Investigating the Utility of Explainable Artificial Intelligence for Neuroimaging-Based Dementia Diagnosis and Prognosis

    Martin SA, Zhao A, Qu J et al. · Human brain mapping · 2026

  35. 0.68

    CSEPC: a deep learning framework for classifying small-sample multimodal medical image data in Alzheimer's disease

    Liu J, Yu X, Fukuyama H et al. · BMC geriatrics · 2025

  36. 0.67

    A 3D multi-modal multi-scale end-to-end classifier for Alzheimer's disease diagnosis

    Khojaste-Sarakhsi M, Haghighi SS, Fatemi Ghomi SMT · Medical engineering & physics · 2025

  37. 0.67

    Cost-Sensitive Weighted Contrastive Learning Based on Graph Convolutional Networks for Imbalanced Alzheimer's Disease Staging

    Hu Y, Wang J, Zhu H et al. · IEEE transactions on medical imaging · 2024

  38. 0.67

    A 3D decoupling Alzheimer's disease prediction network based on structural MRI

    Wei S, Yang W, Wang E et al. · Health information science and systems · 2025

  39. 0.66

    Multi-Modal Fusion and Longitudinal Analysis for Alzheimer's Disease Classification Using Deep Learning

    Muksimova S, Umirzakova S, Baltayev J et al. · Diagnostics (Basel, Switzerland) · 2025

  40. 0.65

    Alzheimer disease predicting from clinical and MRI data using DeepALZNET dual pathway framework

    Bekhet S, Saad N, Farag S · Scientific reports · 2025

  41. 0.65

    An efficient method for early Alzheimer's disease detection based on MRI images using deep convolutional neural networks

    Dardouri S · Frontiers in artificial intelligence · 2025

  42. 0.64

    Detection of brain network abnormalities by graph invariants in Alzheimer's disease using MRI images

    NallappaBhavithran G, Selvakumar R · Scientific reports · 2025

  43. 0.64

    Diagnosis of Alzheimer's disease using transfer learning with multi-modal 3D Inception-v4

    Yuan Z, Qi N, Zhou Z et al. · Quantitative imaging in medicine and surgery · 2025

  44. 0.64

    Cogninet: an explainable deep learning model for multi-class MRI-based Alzheimer's disease staging

    White T, Rowlands S · International journal of computer assisted radiology and surgery · 2026

  45. 0.63

    A hybrid deep learning architectures and feature extraction techniques for alzheimer disease recognition

    Nivethitha A, Manigandan T · Cognitive neurodynamics · 2025

  46. 0.63

    Multi-Dimensional Feature Adaptive Gating Network for Multi-View and Whole-Brain Magnetic Resonance Imaging-Based Alzheimer's Disease Classification

    Zhou Y, Zhu L, Liu Z et al. · Journal of visualized experiments : JoVE · 2026

  47. 0.62

    Hybrid quaternion-based denoising and deep feature fusion for early Alzheimer's prognosis

    Subramani S, Priya SB · Health information science and systems · 2026

  48. 0.62

    FROG: A Fine-Grained Spatiotemporal Graph Neural Network With Self-Supervised Guidance for Early Diagnosis of Alzheimer's Disease

    Zhang S, Wang Q, Wei M et al. · IEEE journal of biomedical and health informatics · 2025

  49. 0.61

    Enhanced particle swarm optimization for feature selection in SVM-based Alzheimer's disease diagnosis

    Zhang Q, Sheng J, Zhou R et al. · Scientific reports · 2025

  50. 0.61

    Early detection of Alzheimer's disease progression stages using hybrid of CNN and transformer encoder models

    Almalki H, Khadidos AO, Alhebaishi N et al. · Scientific reports · 2025

  51. 0.60

    Feature Importance Analysis and Machine Learning for Alzheimer's Disease Early Detection: Feature Fusion of the Hippocampus, Entorhinal Cortex, and Standardized Uptake Value Ratio

    Hassouneh A, Bazuin B, Danna-Dos-Santos A et al. · Digital biomarkers · 2024

  52. 0.60

    DIPOG: A dynamic pooling graph neural network with spatial-temporal-frequency awareness for diagnosis of Alzheimer's disease

    Zhang S, Huang L, Wang M et al. · Medical image analysis · 2027

  53. 0.60

    Biomarker-Conditioned Vision Transformers with Deformable Biomarker Attention for Alzheimer's Disease Classification

    Alsubaie MG, Luo S, Shaukat K et al. · Journal of imaging informatics in medicine · 2026

  54. 0.59

    A Novel Graph Neural Network Framework for Brain Age Prediction

    He S, Yang B, Chen Y et al. · Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2025

  55. 0.58

    Explainable artificial intelligence for neuroimaging-based dementia diagnosis and prognosis

    Martin SA, Zhao A, Qu J et al. · medRxiv : the preprint server for health sciences · 2025

  56. 0.58

    3-Way hybrid analysis using clinical and magnetic resonance imaging for early diagnosis of Alzheimer's disease

    Farhatullah, Chen X, Zeng D et al. · Brain research · 2024

  57. 0.58

    Alzheimer's disease staging using enhanced inception-ResNet-V2 and improved XceptionNet models for 3D MRI classification and segmentation

    Srilakshmi V, Devarasetty P, Chetana VL et al. · Journal of neuroscience methods · 2026

  58. 0.57

    An interpretable multimodal framework using compact biomarkers and Kolmogorov-Arnold networks improves the early diagnosis of Alzheimer's disease

    Tan D, Song L, Tang Y et al. · Scientific reports · 2026

  59. 0.57

    Information Geometry and Manifold Learning: A Novel Framework for Analyzing Alzheimer's Disease MRI Data

    Akguller O, Balci MA, Cioca G · Diagnostics (Basel, Switzerland) · 2025

  60. 0.56

    CROSS-ATTENTION FUSION OF STRUCTURAL AND DEFORMATION-BASED MRI FEATURES FOR ALZHEIMER'S DISEASE CLASSIFICATION

    Zhang S, Ding X, Caffo B et al. · Proceedings. IEEE International Symposium on Biomedical Imaging · 2026

  61. 0.55

    Progression-Aware and Explainable CNN-Transformer Framework for Multiclass Alzheimer's Disease Staging Using MRI

    Alsalem K, Elbashir MK, Alzahrani AO et al. · Diagnostics (Basel, Switzerland) · 2026

  62. 0.55

    AD diagnosis model based on fusion of heterogeneous brain imaging and genomic data

    Zhang Z, Zhang R, Yang W et al. · Frontiers in neuroscience · 2026

  63. 0.55

    AD-Diff: enhancing Alzheimer's disease prediction accuracy through multimodal fusion

    Han L · Frontiers in computational neuroscience · 2025

  64. 0.55

    A Novel Method to Identify Mild Cognitive Impairment Using Dynamic Spatio-Temporal Graph Neural Network

    An X, Zhou Y, Di Y et al. · IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society · 2024

  65. 0.54

    Prediction of Alzheimer's Disease Based on Multi-Modal Domain Adaptation

    Fu B, Shen C, Liao S et al. · Brain sciences · 2025

  66. 0.54

    Transfer Learning and Neural Network-Based Approach on Structural MRI Data for Prediction and Classification of Alzheimer's Disease

    Momeni F, Shahbazi-Gahrouei D, Mahmoudi T et al. · Diagnostics (Basel, Switzerland) · 2025

  67. 0.53

    Enhancing the early detection of Alzheimer's disease using an integrated CNN-LSTM framework: A robust approach for fMRI-based multi-stage classification

    Farhan S, Haq YU, Khaliq MA et al. · PloS one · 2025

  68. 0.53

    Interpretable Multi-Attention Fusion Mechanisms for Early Detection of Transitional Phases in Alzheimer's Disease

    Lin MC, Kuo PC, Li YT et al. · Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2025

  69. 0.52

    Multi-Architecture Deep Learning for Early Alzheimer's Detection in MRI: Slice- and Scan-Level Analysis

    Bricaud I, Masala GL · International journal of environmental research and public health · 2026

  70. 0.52

    Alzheimer's related dementia severity classification from magnetic resonance imaging using derivative-free optimization of convolutional neural network

    Ganesan SK, Velusamy P, Parthsarathy P et al. · Scientific reports · 2026

  71. 0.51

    Early detection and classification of Alzheimer's disease through data fusion of MRI and DTI images using the YOLOv11 neural network

    Hechkel W, Helali A · Frontiers in neuroscience · 2025

  72. 0.51

    A hybrid CNN-GCN framework for interpretable Alzheimer's disease diagnosis from MRI scans

    Islam J, Lin FY, Lin CY · Neuroscience · 2026

  73. 0.50

    Hybrid representation learning for cognitive diagnosis in late-life depression over 5 years with structural MRI

    Zhang L, Wang L, Yu M et al. · Medical image analysis · 2024

  74. 0.50

    Multimodal multiview bilinear graph convolutional network for mild cognitive impairment diagnosis

    Wu G, Li X, Xu Y et al. · Biomedical physics & engineering express · 2025

07white matter · cerebral61편

  1. 0.94

    Independent prognostic value of peak width of skeletonized mean diffusivity on clinical progression in Alzheimer's disease

    Jarholm JA, Tecelao S, Kirsebom BE et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  2. 0.92

    Spatiotemporal atrophy subtypes in Alzheimer's disease: Neurodegenerative-vascular associations and potential prognostic value

    Mao C, Qiu Y, Li B et al. · NeuroImage · 2026

  3. 0.91

    Quantitative analysis of cerebral vasculature and its clinical effect on cognitive change in Alzheimer's dementia and mild cognitive impairment

    Kim T, Zhang K, Zhu T et al. · Journal of the neurological sciences · 2025

  4. 0.90

    Data-driven subtypes of Alzheimer's Disease: A multicohort study

    Metz A, Polizzi C, Moqadam R et al. · medRxiv : the preprint server for health sciences · 2026

  5. 0.90

    Baseline MRI markers and clinical outcomes during anti-amyloid beta therapy: A real-world study in a Japanese dementia center

    Kujuro Y, Saito M, Maruko M et al. · The journal of prevention of Alzheimer's disease · 2026

  6. 0.89

    Association between T1w/T2w ratio in white matter and cognitive function in Alzheimer's disease

    Lee SN, Woo SH, Lee EJ et al. · Scientific reports · 2024

  7. 0.88

    Brain aging and cognitive decline accelerate beyond a threshold of periventricular white matter hyperintensity

    Gupta NK, Yadav N, Tiwari V · Cerebral cortex (New York, N.Y. : 1991) · 2025

  8. 0.88

    Subthreshold early white-matter hyperintensity increase predicts accelerated hippocampal and whole-brain atrophy in anti-amyloid-beta immunotherapy

    Amemiya S, Takao H, Matsumoto S et al. · Journal of Alzheimer's disease : JAD · 2026

  9. 0.88

    Topography of Juxtaventricular white matter hyperintensities and cognitive associations in Alzheimer's disease: a dual-cohort study

    Bao YW, Ji YQ, Wang LN et al. · European radiology experimental · 2026

  10. 0.87

    Integrative MR Imaging Interpretation in Cognitive Impairment with Alzheimer's Disease, Small Vessel Disease, and Glymphatic Function-Related MR Parameters

    You SH, Kim B, Kim I et al. · Academic radiology · 2025

  11. 0.87

    Head-to-head comparison of diffusion imaging markers for cognitive decline and risk of dementia: The population-based Rotterdam Study

    Rosbergen MT, Wolters FJ, Ikram MA et al. · Imaging neuroscience (Cambridge, Mass.) · 2026

  12. 0.86

    Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA)

    Bregman N, de Barros NP, Nathan T et al. · Alzheimer's research & therapy · 2026

  13. 0.86

    Longitudinal changes in white matter hyperintensity volume accelerate across the Alzheimer's continuum in adults with Down syndrome

    Lao P, Edwards N, Flores-Aguilar L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  14. 0.86

    Neurovascular decoupling: An early indicator of cognitive decline

    van Dijk SE, Drenth N, Hafkemeijer A et al. · Journal of Alzheimer's disease : JAD · 2026

  15. 0.86

    Robust, fully-automated assessment of cerebral perivascular spaces and white matter lesions: a multicentre MRI longitudinal study of their evolution and association with risk of dementia and accelerated brain atrophy

    Barisano G, Iv M, Choupan J et al. · EBioMedicine · 2025

  16. 0.85

    Dynamics of Cognitive Impairment in MCI Patients over a Three-Year Period: The Informative Role of Blood Biomarkers, Neuroimaging, and Genetic Factors

    Morozova I, Zorkina Y, Berdalin A et al. · Diagnostics (Basel, Switzerland) · 2024

  17. 0.85

    Impact of Cerebral Microbleeds on Tau-Associated Cognitive and Structural Decline

    Jung YH, Cho J, Lee SY et al. · Neurology · 2026

  18. 0.85

    Hippocampal mediation in the lipid-Alzheimer's disease pathway: A high-dimensional mediation analysis stratified by APOE and sex

    Cao Y, Fan Y, Meng Q et al. · Alzheimer's & dementia (New York, N. Y.) · 2026

  19. 0.84

    Alzheimer's disease diagnostic progression is associated with cerebrovascular disease and neuroinflammation in adults with Down syndrome

    Edwards NC, Lao PJ, Alshikho MJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  20. 0.83

    Perivascular Spaces as Determinants of Amyloid, Tau, and Vascular Biomarker Progression

    Low A, Gunter JL, Hu M et al. · Annals of neurology · 2026

  21. 0.82

    The clinical and neuropsychological profiles of Alzheimer's disease with white matter hyperintensity in North China

    Chen Y, Wang Y, Zhang M et al. · Frontiers in neurology · 2024

  22. 0.82

    Perivascular space and white matter hyperintensities in Alzheimer's disease: associations with disease progression and cognitive function

    Schirge PM, Perneczky R, Taoka T et al. · Alzheimer's research & therapy · 2025

  23. 0.82

    Glymphatic system dysfunction as a predictor of cognitive decline and incident dementia

    Li C, Li WX, Liu ZY et al. · Journal of Alzheimer's disease : JAD · 2026

  24. 0.80

    Association of choroid plexus volume with white matter microstructure, glymphatic function, and peripheral systemic inflammation in Alzheimer's disease

    Xia H, Feng Y, Zhu H et al. · Translational psychiatry · 2025

  25. 0.78

    Association of small vessel disease progression with longitudinal cognitive decline across mild cognitive impairment

    Wang J, Debora A, Chen L et al. · Journal of Alzheimer's disease : JAD · 2025

  26. 0.77

    Regional growth rates of white matter hyperintensities are associated with beta-amyloid burden

    Strain JF, Rahmani M, Phuah CL et al. · Neurobiology of aging · 2026

  27. 0.77

    Modeling the age-specific incidence of mild cognitive impairment incorporating the time-varying relationship of Alzheimer's disease biomarkers over 28 years

    Wang K, Zhu Y, Albert M et al. · Journal of Alzheimer's disease : JAD · 2026

  28. 0.76

    Tissue- and compartment-resolved brain age reveals vascular-metabolic and neurodegenerative aging

    Kim H, Zang C, Lee J et al. · Research square · 2026

  29. 0.75

    Association Between Single Nucleotide Polymorphisms in the Aquaporin-4 Gene and Longitudinal Changes in White Matter Free Water and Cognitive Function in Non-Demented Older Adults

    Liu L, Zeng Q, Luo X et al. · Human brain mapping · 2025

  30. 0.75

    Brain atrophy and clinical diagnosis independently predict default mode network failure across the Alzheimer's disease continuum

    Alghamdi M, von Wegner F, Chan DKY et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  31. 0.74

    WMH-DualTasker: A Weakly Supervised Deep Learning Model for Automated White Matter Hyperintensities Segmentation and Visual Rating Prediction

    Wu Y, Dong Z, Li HB et al. · Human brain mapping · 2025

  32. 0.74

    Divergent white matter metabolic signature patterns indicate impending cognitive decline in aging and dementia

    Zhang W, Raghavan S, Tian J et al. · Nature communications · 2026

  33. 0.72

    The protective role of education in white matter lesions and cognitive decline

    Elkana O, Beheshti I · Brain and cognition · 2025

  34. 0.70

    Factors and brain imaging features associated with cognition in oldest-old patients with Alzheimer-type dementia

    Hanyu H, Koyama Y, Umekida K et al. · Journal of the neurological sciences · 2024

  35. 0.66

    MRI evaluation of cerebral perivascular spaces predicts amyloid-related imaging abnormalities risk in preclinical Alzheimer's disease

    Bigjahan B, Cavallari M, Barisano G · Frontiers in dementia · 2026

  36. 0.66

    Impact of cerebral small vessel disease on cognitive outcomes in early age at onset MCI and dementia: Findings from the DIASPORA study

    Naftali J, Glik A, Eliahou R et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  37. 0.66

    Centrum Semiovale Perivascular Spaces Predict First Hemorrhagic Lesion in Asymptomatic Amyloid-Positive Individuals

    Alten B, Gokcal E, Sperling RA et al. · Annals of neurology · 2026

  38. 0.66

    White matter hyperintensity burden predicts domain-specific cognitive decline across the Alzheimer's disease continuum

    Nasiri H, Khosravi F, Saberian P et al. · Scientific reports · 2025

  39. 0.65

    Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage

    Joseph-Mathurin N, Feldman RL, Lu R et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  40. 0.63

    Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome-associated Alzheimer's disease

    Morcillo-Nieto AO, Franquesa-Mullerat M, Zsadanyi SE et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  41. 0.63

    Cerebrovascular lesion loads and accelerated brain aging: insights into the cognitive spectrum

    Beheshti I, Potvin O, Dadar M et al. · Frontiers in dementia · 2024

  42. 0.60

    Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities

    Cha WJ, Yi D, Ahn H et al. · Alzheimer's research & therapy · 2024

  43. 0.60

    Dynamic imaging markers of incident microhemorrhages and superficial siderosis in the A4 study: A longitudinal person-interval analysis

    Hill C, Morgan H, Michopoulou S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  44. 0.59

    Impact of Vitamin B12, Folate and Homocysteine in Modulating Cognitive Functions and the Brain's White Matter Hyperintensity in Alzheimer's Disease

    Sah RP, Cs V, Jayaram S et al. · Annals of neurosciences · 2026

  45. 0.59

    Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases

    Sanchez E, Coughlan GT, Wilkinson T et al. · Neurology · 2025

  46. 0.58

    Integrated Analysis of Cerebral Small Vessel Disease and Facial Soft-Tissue Markers in the Alzheimer's Disease Continuum

    Bernetti C, Di Gennaro G, Roberti R et al. · Brain sciences · 2026

  47. 0.58

    Multimarker Cerebral Small Vessel Disease Score and Risk of Incident Dementia in the Framingham Heart Study

    Pinheiro A, Ekenze O, Aparicio HJ et al. · Neurology · 2025

  48. 0.58

    Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals with a family history of Alzheimer's disease

    Tremblay SA, Nathan Spreng R, Wearn A et al. · Neurobiology of aging · 2025

  49. 0.57

    Arrhythmias, dementia risk, and neurodegeneration: a cohort study

    Lu W, Weng S, Wang Y et al. · European heart journal · 2026

  50. 0.55

    Accelerated Cognitive Decline in Late Life Depression: The Role of Amyloid-beta, Cortico-Limbic Volume, and White Matter Hyperintensities

    Rhodes E, Insel PS, Kassel M et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2026

  51. 0.55

    Sex-Specific Adaptations in Alzheimer's Disease and Ischemic Stroke: A Longitudinal Study in Male and Female APP(swe)/PS1(dE9) Mice

    Lohkamp KJ, Timmer N, Sole Guardia G et al. · Life (Basel, Switzerland) · 2025

  52. 0.55

    Correlation of White Matter Lesions, Cerebral Blood Flow, and Cognitive Decline in Patients With Alzheimer's Disease and Vascular Dementia

    Ye M, Pan X · Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2026

  53. 0.54

    Heterogeneous trajectories of executive function in clinical Alzheimer's disease: Results from the 3C study

    Amieva H, Dussartre M, Philipps V et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  54. 0.53

    Blood-Brain Barrier Permeability Is Associated With Cognitive Functioning in Normal Aging and Neurodegenerative Diseases

    Hergert DC, Gaasedelen O, Ryman SG et al. · Journal of the American Heart Association · 2024

  55. 0.52

    Cerebrovascular disease emerges with age and Alzheimer's disease in adults with Down syndrome

    Lao P, Edwards N, Flores-Aguilar L et al. · Scientific reports · 2024

  56. 0.52

    Diabetes and neurodegeneration in cognitively unimpaired older adults: implications for cognition

    Tsiknia AA, Tennant VR, Davison M et al. · Brain : a journal of neurology · 2026

  57. 0.51

    Association of Medial Temporal Lobe Cerebrovascular Reactivity and Memory Function in Older Adults With and Without Cognitive Impairment

    Kapoor A, Dutt S, Engstrom AC et al. · Neurology · 2025

  58. 0.51

    Strategic locations of white matter hyperintensities associated with cognitive impairment across the cognitive spectrum among rural older adults: a population-based study

    Li C, Wang J, Chen Z et al. · Alzheimer's research & therapy · 2026

  59. 0.51

    A study on the correlation between APOE gene polymorphism, white matter hyperintensities, and neuropsychiatric symptom phenotypes in Alzheimer's disease

    Fan W, Wang Z, Wan S et al. · Frontiers in psychiatry · 2026

  60. 0.51

    Impaired kidney function, cerebral small vessel disease and cognitive disorders: the Framingham Heart Study

    Kelly DM, Pinheiro AA, Koini M et al. · Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024

  61. 0.50

    Cerebrovascular disease is associated with Alzheimer's plasma biomarker concentrations in adults with Down syndrome

    Edwards NC, Lao PJ, Alshikho MJ et al. · Brain communications · 2024

08review · treatment6편

  1. 0.85

    Integrating imaging and omics for enhanced subtyping of mild cognitive impairment associated with Alzheimer's disease

    Afxenti S, Zachariou M, Athieniti E et al. · Journal of translational medicine · 2025

  2. 0.75

    Metabolism fluctuation coupling can track the progression of dementia and describe MST1 gene-related pathology

    Sheng J, Yang Z, Wang Y et al. · Communications medicine · 2026

  3. 0.65

    Monitoring Alzheimer's disease-related fluid microenvironment changes using magnetic resonance-based electrical conductivity imaging

    Choi BK, Park JA, Kim TH et al. · Journal of Alzheimer's disease : JAD · 2026

  4. 0.64

    Glia inflammation and cell death pathways drive disease progression in preclinical and early AD

    Woo MS, Therriault J, Hosseini SA et al. · EMBO molecular medicine · 2025

  5. 0.62

    Uncovering neural substrates across Alzheimer's disease stages using contrastive variational autoencoder

    Tang Y, Yang C, Wang Y et al. · Cerebral cortex (New York, N.Y. : 1991) · 2024

  6. 0.51

    Longitudinal changes of blood-brain barrier and transcytolemmal water exchange permeability in Alzheimer's disease mice: A non-contrast MRI study

    Xiong C, Yu Z, Yin Y et al. · NeuroImage · 2025